Top

Rebecca M. Howell, PhD

Department of Radiation Physics, Division of Radiation Oncology

About Rebecca M. Howell

I am a medical physicist with 20 years of clinical experience, a tenured Professor, certified by the American Board of Radiology in Therapeutic Radiologic Physics, and a Fellow of the American Association of Physicists in Medicine. I direct the Radiation Dosimetry Services (RDS) and the Late Effects Group. Our team includes 16 staff and three graduate students. I am the Deputy Director of the Medical Physics Graduate Program at the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences.

The Radiation Dosimetry Services (RDS) provides independent peer review of beam output calibrations for external beam radiotherapy machines through a mail audit system. Patient safety is directly linked to accurate beam output. Annually, we monitor ~12,000 beams at >1,200 radiotherapy centers worldwide. We also monitor doses for blood irradiators (blood banks) and offer end-to-end peer review for small animal irradiators (research labs). https://rds.mdanderson.org

The Late Effects Group focuses on radiation therapy (RT)-related late effects. Our studies quantify relationships between doses from RT and late effects in cancer survivors. Dose-response relationships can be used to establish normal tissue objectives for RT treatment planning for individual patients in clinics around the world and to improve clinical practice and survivorship guidelines. My lab developed novel methods to reconstruct organ and body region doses for survivors in studies of multi-institutional national and international cohorts including the Childhood Cancer Survivor Study (CCSS), St. Jude Lifetime, Adult Life after Childhood Cancer in Scandinavia, and Dutch Childhood Oncology Group. We have reconstructed doses for >20,000 survivors.

Primary Appointment

President of the Faculty, Department of Graduate School of Biomedical Sciences, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center UT Health, Houston, Texas

Director, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UT Health, Houston, Texas

Professor (term tenure), Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Radiation Dosimetry Services, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Director, Late Effects Studies, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor (term tenure), Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX

Faculty (Full), MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, TX

Education & Training

Degree-Granting Education

2005	University of Texas Health Science Center, San Antonio, Texas, US, Medical Physics, Ph.D
2001	University of Texas Health Science Center, San Antonio, Texas, US, Medical Physics, M.S
1997	University of Texas at El Paso, El Paso, Texas, US, Chemistry, BS

Licenses & Certifications

2009	Medical Physicist License awarded by the Texas Medical Board
2005	American Board of Radiology - Therapeutic Radiologic Physics

Experience & Service

Faculty Academic Appointments

Associate Professor (with term tenure), Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020

Assistant Professor (tenure track), Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - 2014

Affiliate Assistant Professor, G. W. Woodruff School of Mechanical Engineering, Atlanta, GA, 2005 - 2007

Assistant Professor (clinical, non-tenure track), Department of Radiation Oncology, Emory School of Medicine, Atlanta, GA, 2005 - 2007

Administrative Appointments/Responsibilities

President of the Faculty, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UT Health, Houston, Texas, 2025 - Present

Director, Department of Medical Physics Graduate Program, The University of Texas MD Anderson Cancer Center UT Health, Houston, Texas, 2022 - Present

Director, Radiation Dosimetry Services, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Deputy Director, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center UT Health, Houston, TX, 2016 - 2022

Director, Late Effects Studies, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - Present

Associate Director, Radiation Dosimetry Services, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016

Director of Admissions, Institutional Committee, Department of Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2016

Other Professional Positions

Medical Physicist, Emory School of Medicine, Atlanta, GA, 2002 - 2005

Junior Medical Physicist, Piedmont Hospital, Atlanta, GA, 2001 - 2002

Extramural Institutional Committee Activities

Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Minority Outreach and Social Media Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2023

Member, The University of Texas MD Anderson Cancer Center, Radiation Oncology, Division Head Advisory Committee, The University of Texas MD Anderson Cancer Center, 2019

Alternate Member, MD Anderson Cancer Center, UT Health Graduate School of Biomedical Sciences, Membership Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2021

Committee Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, 2018-2019 Dr. John Kopchick Research Award, The University of Texas MD Anderson Cancer Center, 2018

Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Medical Physics Program, Curriculum Review Committee, The University of Texas MD Anderson Cancer Center, 2015 - Present

Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Medical Physics Program, Admissions Committee, The University of Texas MD Anderson Cancer Center, 2014 - Present

Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Medical Physics Program, Aaron Blanchard Award Nominating Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2019

Member, The University of Texas MD Anderson Cancer Center Advisory Board for the Department of Scientific Publications, The University of Texas MD Anderson Cancer Center, 2012 - 2018

Member, The University of Texas MD Anderson Cancer Center Survivorship Research Advisory Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2019

Member, The University of Texas MD Anderson Cancer Center Faculty Senate, The University of Texas MD Anderson Cancer Center, 2011 - 2014

Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Medical Physics Program, Steering Committee, The University of Texas MD Anderson Cancer Center, 2011 - Present

Member, Radiation Safety Committee, Georgia Institute of Technology, 2005 - 2007

Member, Radiation Oncology Residency Interview Committee, Emory University, 2003 - 2007

Editorial Activities

Editor/Service on Editorial Board(s), International Journal of Particle Therapy, 2018 - 2024

Associate Editor, International Journal of Particle Therapy, 2018 - 2024

Associate Editor, Medical Physics Journal, 2014 - 2023

Guest Associate Editor, Medical Physics Journal, 2010 - 2014

Section Editor, Journal Applied Clinical Medical Physics, 2009 - 2012

Board of Editors, Journal Applied Clinical Medical Physics, 2009 - 2012

Honors & Awards

2019	The Laundauer Lecturer, The Health Physics Society
2018	Editor-in-Chief Award for the calendar year for an outstanding General Medical Physics Article published in 2017 for your paper, Journal of Applied Clinical Medical Physics 18(5), 285-292(2017)
2017	President's Recognition for Faculty Excellence Award in Education and Mentorship, The University of Texas M.D. Anderson Cancer Center
2015	Fellow, American Association of Physicists in Medicine
2015	The Gunar K. Zagars Teaching Award for Outstanding Resident Education in Physics, Radiation Biology, or Dosimetry, The University of Texas M. D. Anderson Cancer Center
2011	Editor's Choice, Article in Physics in Medicine & Biology: The clinical impact of the couch top and rails on IMRT and arc therapy, Phys Med Biol 56:7435-7447
2010	Editor's Choice, Article in Physics in Medicine & Biology: Risk of second malignant neoplasm following proton versus intensity modulated photon radiotherapy for hepatocellular carcinoma, Phys Med Biol 55:7055-7065
2010	Scholarship Recipient, Association of American Medical Colleges (AAMC) Early Career Women Faculty Professional Development Seminar
2009	Featured article in Physics in Medicine & Biology Highlights of 2009 collection: Treatment vault shielding for a flattening filter-free medical linear accelerator, Phys Med Biol 54(5):1265-73
2008	Best Paper Award, Medical Applications Session, 11th International Conference on Radiation Shielding
2007	Junior Faculty Enhancement Award, Oakridge Associated University
2004	Travel Scholarship, 10th International Conference on Radiation Shielding, Madeira, Portugal
2004 - 2007	Educator of the Year Award, Association of Residents in Radiation Oncology, Emory University
2003	Travel Scholarship, American Association of Physicists in Medicine Summer School

Professional Memberships

International Society for Radiation Epidemiology and Dosimetry

2020 - 2023

Pediatric Normal Tissue Effects in Clinic (PENTEC)

2017 - Present

Society of Directors of Academic Medical Physics Programs

2016 - Present

Childhood Cancer Survivor Study, St. Jude Children's Research Hospital

2015 - Present

Radiological Society of North America

2013 - 2020

American Association for Radiation Oncology

2013 - Present

American Board of Radiology

2012 - Present

American Radium Society

2007 - Present

Commission on Accreditation of Medical Physics Education Programs

2006 - Present

American Nuclear Society

2003 - Present

American Association of Physicists in Medicine

1998 - Present

American Chemical Society University of Texas at El Paso Chapter

1994 - 1997

Selected Presentations & Talks

Local Presentations

2023. Panelist, Shattering the Glass Ceiling: The Status of Women in Medical Physics. Conference. Society of Directors of Academic Medical Physics Programs. Houston, TX, US.
2018. Therapy related cardiac risk in the Childhood Cancer Survivor Study. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2017. Normal Tissue Injury - Normal tissue complications from radiation therapy. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2017. Normal Tissue Injury - Dosimetry for epidemiological late effects studies. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2010. Advanced photon therapy for prostate cancer. Conference. Rice University. Houston, TX, US.

Regional Presentations

2013. The Childhood Cancer Survivor Study (CCSS) – Discussion of recent CCSS publications. Conference. The University of Texas MD Anderson Cancer Center, US.
2012. Radiation Therapy Related Cardiac Effects, Current State of Knowledge. Conference. The University of Texas MD Anderson Cancer Center, US.
2010. Radiation Related Late Effects. Conference. The University of Texas MD Anderson Cancer Center, US.
2010. Presentation to Prospective Medical Physics Graduate Students on Research Opportunities in the Department of Radiation Physics. Conference. The University of Texas MD Anderson Cancer Center, US.
2009. RapidArc at M.D. Anderson. Conference. The University of Texas MD Anderson Cancer Center, US.
2009. Commissioning and Quality Assurance of RapidArc. Conference. The University of Texas MD Anderson Cancer Center, US.
2009. Volumetric Modulated Arc Therapy. Conference. The University of Texas MD Anderson Cancer Center, US.
2008. Neutrons in High Energy X-Ray Therapy. Conference. The University of Texas MD Anderson Cancer Center, US.
2007. Portal Dosimetry for IMRT QA and Neutron Contamination Studies. Conference. The University of Texas MD Anderson Cancer Center, US.

National Presentations

2023. Invited Speaker, Advances in Radiation Dosimetry Modeling to Define Late Cardiac Effects of Survivors of Childhood Cancer, American Society for Therapeutic Radiology & Oncology. Invited. Annual Meeting. San Diego, CA, US.
2023. Invited Speaker Panel Presentation, The Role of the Non-Clinical Physicist in a Clinical Realm - Research is Changing and Improving Clinical Outcomes. Invited. Invited Speaker Panel Presentation, The Role of the Non-Clinical Physicist in a Clinical Realm - Research is Changing and Improving Clinical Outcomes. Orlando, FL, US.
2022. Invited Speaker Panel Presentation: PENTEC: Pediatric Normal Tissue Effects in the Clinic: An international collaboration - modeling normal-tissue dose-response data in developing children, knowledge gaps and the path forward, retrospective dose reconstruction, estimating organ dose, and dose-volume metrics using modeled anatomy. Invited. American Society for Therapeutic Radiology & Oncology. San Antonio, TX, US.
2022. Moderator, Presidential Symposium II: Prevention and Mitigation of Radiation Toxicity. Invited. American Society for Therapeutic Radiology & Oncology. San Antonio, TX, US.
2022. Scientific Symposium Presentation: Addressing cardiotoxicity in cancer therapies, radiation therapy-related cardiac disease in childhood cancer survivors. Invited. American Association of Physicists in Medicine. Washington, DC, US.
2019. Education Symposium Presentation: Radiation therapy-related cardiac risk in childhood cancer survivors - informing clinical decisions, retrospective cardiac dosimetry. Invited. American Society for Radiation Oncology. Chicago, IL, US.
2019. Harmonizing imaging protocols: impact on radiomics Survival prediction in large patient cohorts. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. Sensitivity analysis of common beam modeling parameters in the Eclipse treatment planning system on IROC head and neck phantom results. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. . Development of an enhanced heart model with substructures for cardiac dosimetry in late effect studies. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. Implementation of 3D computational human phantoms in RayStation for retrospective studies in late effects. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. Examining the magnitude of dose calculation errors as a component of IROC lung and spine phantom failures. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. 3D, CT-free breast treatment planning simulation for low- and middle-income countries: proof of concept. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. Plenary Presentation: Radiation therapy related late effects. Invited. Health Physics Society. Orlando, FL, US.
2019. Dose estimation for a PENTEC late effects study. Conference. American Association of Physicists in Medicine. San Antonio, TX, US.
2019. Plenary Session Presentation: Report from the radiation physics center. Invited. Childhood Cancer Survivor Study. Atlanta, GA, US.
2018. Keynote Presentation: Neutrons in proton therapy. Invited. Particle Therapy Co-Operative Group North America. Atlanta, GA, US.
2018. Design and feasibility of 3D printed tissue compensators for postmastectomy radiation therapy. Conference. American Society for Therapeutic Radiology & Oncology 59th Annual Meeting. San Antonio, TX, US.
2018. Development of an independent peer review system for a small animal irradiator. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Treatment planning system beam modeling parameters exhibit high variation among radiotherapy institutions. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Harmonized CT protocols for high quality radiomics studies. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Automated detection of vertebral body metastases for fully-automated palliative radiotherapy using transfer learning. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Design and validation of 3D printed patient specific tissue compensators for post mastectomy radiation therapy. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Validation of patient-specific 3D-printed bolus caps for clinical use in total scalp irradiation. Conference. American Association of Physicists in Medicine Annual Meeting, 60th Annual Meeting. Nashville, TN, US.
2018. Best Practices: Project-based learning (PBL) in medical Physics. Conference. American Association of Physicists in Medicine Workshop on Improving the Teaching and Mentoring of Medical Physics. Nashville, TN, US.
2018. Development of a Clinical Workflow for Patient-Specific 3D-Printed Bolus Caps for Total Scalp Irradiation. Conference. Young Investigators Symposium, American Association of Physicists in Medicine Annual Spring Clinical Meeting. Las Vegas, NV, US.
2017. Keynote Presentation: Neutrons in proton therapy. Invited. Particle Therapy Co-Operative Group North America, 4th Annual Conference. Chicago, IL, US.
2017. Volumetric dose-effect analysis of late cardiotoxicity: a report from the childhood cancer survivor study (CCSS). Conference. American Society for Therapeutic Radiology & Oncology 59th Annual Meeting. San Diego, CA, US.
2017. Discussant for ePoster Session: Outcome analysis and modeling. Invited. American Society for Therapeutic Radiology & Oncology. San Diego, CA, US.
2017. Fully-automated treatment planning for cervical cancer radiotherapy. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Comparison of single and dual material 3D printed patient-specific radiotherapy phantoms. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Material matters: concerns with 3D printed material consistency. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Dual-material 3D printing of an anthropomorphic head phantom. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Experiences at MD Anderson Cancer Center for normal tissue dose reconstructions. Invited. American Association of Physicists in Medicine. Denver, CO, US.
2017. Use and validation of contoured 3D-printed neck compensators for total body irradiation. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Results from 15 Years of independent peer review of beam output at more than 2000 academic and non-academic institutions. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Comparison of parameter calculation algorithms for DCE-MRI: results from a multi-institutional study. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Assessment of the accuracy of DIR on MR images using velocity and an in-house demons algorithm. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Results from voluntary independent external peer review of beam output. Invited. American Association of Physicists in Medicine. Orlando, FL, US.
2017. Results from voluntary independent external peer review of beam output. Invited. American Association of Physicists in Medicine. Los Angeles, CA, US.
2016. Use of flexible 3-Dimensional printed materials for in-house fabrication of patient-specific issue equivalent compensators for postmastectomy radiation therapy. Conference. American Society for Therapeutic Radiology & Oncology. Boston, ME, US.
2016. Practical implementation of deep inspiration breath hold techniques for breast radiation therapy. Invited. American Association of Physicists in Medicine Annual Meeting. Washington, DC, US.
2016. The many paths of medical physics: the path of an academic physicist. Invited. Medical Physics Student Meeting. Washington, DC, US.
2016. Making the most of a one hour lecture with alternative teaching methodologies: implementing project-based and flipped learning. Invited. Education Council Symposium. Washington, DC, US.
2016. Tissue-equivalence of 3D printed materials. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2016. Characterization of electron beam out-of-field Doses and neutron contamination from modern Varian and Elekta linear accelerators. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2016. Automating treatment planning for cervical cancer in low- and middle- income countries. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2016. Identifying treatment planning system errors in IROC-H phantom irradiations. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2016. Investigation of longitudinal salivary gland DCE-MRI changes. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2016. Use and Validation of flexible 3D printed tissue compensators for post-mastectomy radiation therapy. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2015. Poster Presentation, Co-Author. Dosimetric impact of implementing metal artifact reduction methods and metal energy deposition kernels for photon dose calculations. Conference. American Association of Physicists in Medicine. Anaheim, CA, US.
2015. Poster Presentation, 2nd Author. Validation of a secondary TPS for IROC-H recalculation of anthropomorphic phantoms. Conference. American Association of Physicists in Medicine. Anaheim, CA, US.
2015. Oral Presentation, Co-Author. An evaluation of out-of-field doses for electron beams from modern Varian and Elekta Linear accelerators. Conference. American Association of Physicists in Medicine. Anaheim, CA, US.
2015. Oral Presentation, Senior Author. Pseudo in vivo patient dosimetry using a 3D-printed patient-specific phantom. Conference. American Association of Physicists in Medicine. Anaheim, CA, US.
2015. Dosimeters and phantoms for measuring non-target photon, electron, and neutron doses. Invited. American Association of Physicists in Medicine. Anaheim, CA, US.
2015. AAPM Task Group 158: Measurement Approaches for Doses outside the Treatment Volume from External-beam Radiation. Conference. European Society for Radiotherapy and Oncology Annual Meeting. Barcelona, Spain, US.
2015. Treatment planning fundamentals - basics of breast planning. Invited. American Association of Physicists in Medicine Spring Clinical Meeting. St. Louis, MO, US.
2014. Toward developing survivorship care plans for breast cancer patients at high risk for radiation-related cardiac effects. Conference. American Society for Therapeutic Radiology & Oncology 56th Annual Meeting. San Francisco, CA, US.
2014. Multi-institutional data pooling. Invited. American Association of Physicists in Medicine Annual Meeting. Austin, TX, US.
2014. Project-based learning. Invited. American Association of Physicists in Medicine Annual Meeting. Austin, TX, US.
2014. Evaluation of three commercial metal artifact reduction methods for CT simulations in radiation therapy treatment planning. Conference. American Association of Physicists in Medicine 56th Annual Meeting. Austin, TX, US.
2014. A survey of IMRT QA practices for more than 800 institutions. Conference. American Association of Physicists in Medicine 56th Annual Meeting. Austin, TX, US.
2013. Measurements of secondary neutron spectrum and dose equivalent from a 250 MeV passively scattered proton beam using an extended range bonner sphere spectrometer. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Equivalent dose in children receiving craniospinal irradiation with photons in a developing country or with protons in a developed country. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. A comprehensive investigation of dosimetric uncertainties in junction region of breast superclavicular and tangential fields. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Risk of developing a second cancer in the breast for Hodgkin lymphoma patients receiving carbon ion therapy versus proton. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Voxelized second cancer risk calculation - comparison of proton and photon radiotherapies for Hodgkin lymphoma. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Dosimetric impact of implementing kernel hardening and material-specific kernels in the convolution/superposition method. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Risks of cardiac toxicity in pediatric patients receiving photon or proton radiotherapy. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Project-based learning - expanding course content with a broad-scope project. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Evaluation of setup uncertainties for electron boost field treated using compression device for breast cancer irradiation. Conference. American Association of Physicists in Medicine 55th Annual Meeting. Indianapolis, IN, US.
2013. Risk to users/patients from radiation in ioCT. Invited. Annual intraoperative imaging society (iOIS) Meeting - Gateway to the Surgery of the Future. St. Louis, MO, US.
2012. Aspects of physics to consider in your first practice. Invited. Association of Radiation Oncology Residents Career Seminar, Annual meeting of the American Society for Radiation Oncology. Boston, MA, US.
2012. Second cancers from radiation therapy procedures. Invited. American Association of Physicists in Medicine Annual Meeting. Charlotte, NC, US.
2012. Radiogenic second cancer risk differences in female Hodgkin lymphoma patients treated with proton versus photon radiotherapies. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. Evaluation of the Anisotropic Analytical Algorithm (AAA) heterogeneity correction dose calculation in flattened and flattening-filter-free (FFF) beams for high energy x-ray beams using the Radiological Physics Center (RPC) lung phantom. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. Experimental evaluation of deterministic Acuros XB radiation transport algorithm for heterogeneity dose calculation using the Radiological Physics Center's lung phantom. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. Appraisal of Acorus XB and convolution dose algorithms in field junction of breast tangential/superclavicular fields. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. 4D optimization for scanned ion beam tracking therapy for moving tumors. Conference. American Association of Physicists in Medicine 54th Annual Meeting. Charlotte, NC, US.
2012. Radiation-related cardiac effects. Invited. American Association of Physicists in Medicine Annual Spring Clinical Meeting. Dallas, TX, US.
2010. Variations in 6 MV photon energy spectra impact the response of TLD. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. Evaluation of the sensitivity of the Anisotropic Analytical Algorithm (AAA) to the commissioning dataset. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. A method to increase statistical power in micro-clinical trials for second cancers following advanced techniques for pediatric radiotherapy. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. Automated photon Monte Carlo linear accelerator model for calculating in-field and out-of-field dose. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. Evaluation of RapidArc dose delivery using Radiological Physics Center phantoms. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. Neutron-induced electronic failures around a high-energy linear accelerator. Conference. American Association of Physicists in Medicine 52nd Annual Meeting. Philadelphia, PA, US.
2010. Epidemiologic evidence of late effects from radiation therapy. Invited. American Association of Physicists in Medicine Annual Meeting. Philadelphia, PA, US.
2010. Clinical implementation of arc therapy: RapidArc, VMAT. Invited. American College of Medical Physics Annual Meeting. San Antonio, TX, US.
2010. Atomic and nuclear structure, radiation production, treatment machines and dose fundamentals. Invited. American Society for Radiation Oncology Spring Refresher Course. Chicago, IL, US.
2010. Photoneutrons from modern radiation therapy linacs. Invited. American Nuclear Society Joint Topical Meeting, Radiation Protection and Shielding Division, Isotopes and Radiation Division, Biology and Medicine Division. Las Vegas, NE, US.
2009. Overview of recent measurements of photoneutrons from modern radiation therapy linacs. Invited. American Nuclear Society Winter Meeting, Young Professionals Congress. Washington, DC, US.
2009. A low cost energy neutron spectrometer extension to a bonner sphere spectrometer. Conference. 54th Annual Meeting of the Health Physics Society. Minneapolis, MN, US.
2009. Impact of stomach size and position on out-of-field organ dose. Conference. American Association of Physicists in Medicine 51st Annual Meeting. Anaheim, CA, US.
2009. Head leakage, collimator scatter, and patient scatter contributions to out-of-field dose. Conference. American Association of Physicists in Medicine 51st Annual Meeting. Anaheim, CA, US.
2009. How accurate are treatment planning system isodose values outside the treatment field?. Conference. American Association of Physicists in Medicine 51st Annual Meeting. Anaheim, CA, US.
2009. Analytic technique to calculate the out-of-field dose from IMRT Therapy. Conference. American Association of Physicists in Medicine 51st Annual Meeting. Anaheim, CA, US.
2009. Overview of radiation research to improve cancer survival. Conference. American Nuclear Society 2009 Winter Meeting. Washington, D.C, US.
2008. Measurements of high energy neutron spectra with a Bonner sphere extension (BSE) measurement system. Invited. American Nuclear Society Winter Meeting. Reno, NV, US.
2008. Investigation of volumetric arc therapy for head and neck cancer. Conference. 50th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). Boston, ME, US.
2008. Cross section and angular dependence of a Bonner sphere extension. Conference. 2008 Symposium on Radiation Measurements and Applications. Berkely, CA, US.
2008. A comparison of normal tissue doses in patients receiving high-dose thoracic irradiations using two different treatment planning algorithms. Conference. 90th Annual Meeting of the American Radium Society. Leguna Niguel, CA, US.
2008. Dosimetric impact of heterogeneity corrections for thoracic irradiation. Conference. 90th Annual Meeting of the American Radium Society. Leguna Niguel, CA, US.
2007. Preliminary investigation-design of a Bonner sphere extension (BSE) for high energy spectroscopy. Conference. 2007 Annual American Nuclear Society Meeting. Boston, MA, US.
2007. Clinical implementation of portal dosimetry-establishing action levels. Conference. 2007 American Association of Physicists in Medicine Annual Meeting. Minneapolis, MN, US.
2007. Prescription framework for lung dose calculations using anisotropic analytical algorithm for inhomogeneity corrections for lung cancer. Conference. American Radium Society 89th Annual Meeting Proceedings.
2006. Multileaf collimator effects on secondary neutron spectra. Conference. Fast Neutron Detectors and Applications (FNDA). Cape Town.
2006. Investigation of MLC effects on secondary neutron spectra for Varian, Siemens, and Elekta. Conference. 2006 American Association of Physicists in Medicine Annual Meeting. Orlando, FL, US.
2006. The trade-off between neutron dose and skin dose for 6MV versus 18MV for prostate IMRT: Does the 20cm rule still apply?. Conference. 2006 American Society for Therapeutic Radiology & Oncology Annual Meeting. Philadelphia, PA, US.
2005. Measurement of secondary neutron spectra from high energy IMRT and conventional treatment plans using Bonner spheres with Au activation foils. Conference. 2005 American Association of Physicists in Medicine Annual Meeting. Seattle, WA, US.
2004. Preliminary investigation of secondary neutron dose for high energy IMRT. Conference. 2004 American Association of Physicists in Medicine Annual Meeting. Pittsburgh, PA, US.
2003. Measurements of secondary neutron dose from 18 MV IMRT. Conference. 2003 American Nuclear Society Summer Meeting. San Diego, CA, US.
2001. Calculation/comparison of dose to point "H" according to the ABS recommendations for HDR brachytherapy to the dose point "A" based on the revised Manchester system. Conference. 2001 American Society for Therapeutic Radiology & Oncology Annual Meeting. San Francisco, CA, US.
2001. Pulsewidth-dependent nature of laser-induced DNA damage in RPE Cells. Conference. SPIE Biophotonics West. San Jose, CA, US.

International Presentations

2023. Invited Speaker, The Physics of Late Effects Methods for dose reconstruction in late effect studies - What levels of accuracy are reasonable and expected? European Society of Therapeutic Radiation Oncology. Invited. Invited Speaker, The Physics of Late Effects Methods for dose reconstruction in late effect studies - What levels of accuracy are reasonable and expected? European Society of Therapeutic Radiation Oncology. Vienna, AT.
2022. Herman Suit Plenary Presentation: Radiation therapy-related late cardiac disease in childhood cancer survivors. Invited. Radiation Research Society. Waikoloa, US.
2019. Subsequent neoplasm risk associated with rare variants in DNA repair and clinical radiation sensitivity syndrome genes: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2019. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2019. Temporal trends among survivors of rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2019. Long term morbidity and mortality among survivors of infant neuroblastoma: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2019. Chronic health conditions (CHC) and late mortality in survivors of acute lymphoblastic leukemia (ALL) in the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology, US.
2019. Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2019. Cardiac events in survivors of childhood cancer treated in more recent eras: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2019. Frailty among childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2019. Educational attainment in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2019. Late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2019. Effect of heart anatomy on radiation related cardiac risk in the Childhood Cancer Survivor Study. Conference. Annual Meeting. Milan, IT.
2019. A pilot study on the sensitivity of common beam modeling parameters in Eclipse. Conference. European Society for Radiotherapy and Oncology Annual Meeting. Milan, IT.
2019. Keynote Address: Radiation related late effects and secondary neutrons in proton therapy. Invited. Trans Tasmanic Radiation Oncology Group. Melbourne, AU.
2019. Workshop Presentation: Dose outside the treated volume, a workshop on out-of-field dose from photon and particle therapy. Invited. Trans Tasmanic Radiation Oncology Group. Melbourne, AU.
2018. Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Chronic pain and disability in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood Cancer Survivor study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Mortality following breast cancer in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: a report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Subsequent malignant neoplasms (SMNs) among non-irradiated survivors of childhood cancer treated with chemotherapy in the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. Neurofibromatosis type 1 and risk of late outcomes after a primary tumor: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology Annual Meeting. Chicago, US.
2018. 3D printed material uncertainty and its consequences for radiation oncology applications. Conference. Annual Meeting. Barcelona, ES.
2017. Human papillomavirus (HPV)-associated malignancies as subsequent malignant neoplasms (SMN) in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Infection related late mortality in survivors of childhood cancer with asplenia or radiation-induced hyposplenism: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2017. Age-associated vulnerability to treatment-related late cardiotoxicity: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Long-term incidence of venous thromboembolism (VTE) among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Risk of subsequent breast cancer after radiotherapy according to hormone-receptor status: A nested case-control study in the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Temporal trends in late-onset morbidity and mortality after medulloblastoma diagnosed across three decades: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Temporal trends in chronic disease among survivors of childhood cancer diagnosed across three decades: A report from the Childhood Cancer Survivor Study (CCSS). Conference. American Society of Clinical Oncology. Chicago, US.
2017. Psychological and educational outcomes among adolescent survivors of Wilms tumor: A report from the Childhood Cancer Survivor study. Conference. American Society of Clinical Oncology. Chicago, US.
2017. Solid organ transplant after treatment for childhood cancer: A report from the Childhood Cancer Survivor Study. Conference. American Society of Clinical Oncology. Chicago, US.
2017. External neutron spectra measurements for a single room compact proton system. Conference. European Society for Radiotherapy and Oncology. Vienna, AT.
2017. Preparation and fabrication of a full-scale patient-specific 3D-printed radiotherapy phantom. Conference. European Society for Radiotherapy and Oncology. Vienna, AT.
2017. AAPM TG-158 recommendations for neutron dosimetry for photon, electron, and light-ion therapy. Conference. European Society for Radiotherapy and Oncology. Vienna, AT.
2017. Evaluation of single material and multi-material patient-specific, 3D-printed radiotherapy phantoms. Conference. European Society for Radiotherapy and Oncology. Vienna, AT.
2016. Plenary Presentation: Neutron Measurements in Proton Radiation Therapy. Invited. 13th International Conference on Radiation Shielding. Paris, FR.
2016. Low dose late effects from radiation therapy. Invited. Global Academic Programs Conference. Hiroshima, JP.
2016. Measured neutron spectra and dose: craniospinal irradiation on single-room passively scattered proton beamline. Conference. European Society for Radiotherapy and Oncology Annual Meeting. Turin, IT.
2014. Relative risk of cardiac effects with modern cardiac-sparing radiation therapy techniques. Conference. Particle Therapy Co-Operative Group Annual Conference. Shanghai, CN.
2014. Neutron spectrum measurements from 250-MeV passively scattered proton therapy. Conference. European Society for Radiotherapy and Oncology Annual Meeting. Vienna, AT.
2012. Patient specific Monte Carlo for late effects studies. Invited. International Conference on Radiation Shielding and the Topical Meeting of the Radiation Protection and Shielding Division of the American Nuclear Society. Nara, JP.
2011. Comparison of the risk of second malignant neoplasm in a developed country versus a developing country for a 13-year-old girl receiving craniospinal irradiation. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Patient specific out-of-field dose calculation tool for 6MV and 18MV: Development and validation. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Planning, QA, and the role of imaging of localization for head and neck treatments. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Risk of second malignant neoplasms following VMAT and proton arc therapy for prostate cancer. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Radiation-related cardiac effects. Invited. Joint American Association of Physicists in Medicine/Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Calculation of the risks of second cancer and cardiac toxicities for a pediatric patient treated with photon and proton radiotherapies. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Clinical impact of couch top and couch rails on treatment dose for IMRT and arc therapy. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2011. Dosimetric verification of deterministic Acuros XB radiation transport algorithm for IMRT and VMAT plans with the RPC H&N phantom. Conference. 2011 Joint American Association of Physicists in Medicine /Canadian Organization of Medical Physicists Meeting. Vancouver, CA.
2008. Characterization of a gold-and-indium dual-activation-foil-based Bonner sphere system. Conference. 11th International Conference on Radiation Shielding. Pine Mountain, US.
2008. Measurement of high-energy neutron spectra with a Bonner sphere extension (BSE) system. Conference. 11th International Conference on Radiation Shielding. Pine Mountain, US.
2008. Vault shielding for a flattening filter free Clinac. Conference. 11th International Conference on Radiation Shielding. Pine Mountain, US.
2008. Use of a thyroid probe for assaying international contamination following a radioactive dispersal device (RDD). Conference. 11th International Conference on Radiation Shielding. Pine Mountain, US.
2008. Comparison of different unfolding methods for the determination of neutron spectrum and ambient dose equivalent. Conference. 11th International Conference on Radiation Shielding. Pine Mountain, US.
2006. Computed and measured photoneutrons foil activation levels in an ART phantom in the field of a medical accelerator. Conference. 10th Symposium on Neutron Dosimetry (NEUDOS10). Uppsala, SE.
2005. RBE or effective dose to evaluate the effect of different beam energies for intensity modulated radiation therapy. Conference. International Conference Accelerator Applications. Venice, IT.
2004. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT. Conference. 10th International Conference Radiation Shielding, Accelerator Applications. Maderia, PT.

Formal Peers

2023. Radiation therapy-related late cardiac disease in childhood cancer survivors. Invited. Arizona (Virtual), MN, US.
2022. Radiation therapy-related late cardiac disease in childhood cancer survivors. Invited. New York (Virtual), NY, US.
2022. Radiation therapy-related late cardiac disease in childhood cancer survivors. Invited. Madison (Virtual), WI, US.
2022. Radiation therapy-related late cardiac disease in childhood cancer survivors. Invited. Montreal (Virtual), CA.
2019. Dosimetry for epidemiologic studies of conventional radiotherapy. Invited. Bethesda, MD, US.
2019. Medical Physics Careers. Invited. College Station, TX, US.
2019. Late effects from radiation therapy. Invited. College Station, TX, US.
2017. Dose reconstruction methods for radiation epidemiology studies. Invited. London, GB.
2017. Visiting Professor, Radiation Therapy Physics review for Radiation Oncology Residents. Visiting. Houston, TX, US.
2016. Secondary Neutrons from proton radiotherapy. Invited. London, GB.
2016. Visiting Professor, Radiation Therapy Physics review for Radiation Oncology Residents. Visiting. Houston, TX, US.
2015. Lecturer, Fundamentals of breast treatment planning. Visiting. Houston, TX, US.
2015. Radiation dosimetry from treatment. Invited. Bethesda, MD, US.
2014. Visiting Professor, Introduction to Physics and Administrative Aspects of Radiation Oncology. Visiting. Lemont, IL, US.
2014. Visiting Professor, Radiation Therapy for Left-sided Breast Cancer using Deep Inspiration Breath Hold; A Physics Perspective. Visiting. Houston, TX, US.
2013. Visiting Professor, Introduction to Physics and Administrative Aspects of Radiation Oncology. Visiting. Lemont, IL, US.
2013. Lecturer, Technological Advances in Radiation Oncology to Improve Survivorship Outcomes: Radiation Dose Response Models for Cardiac Effects in the Context of Contemporary Radiation Therapy, Cancer Survivorship Institutional Grand Rounds. Visiting. Houston, TX, US.
2013. Contemporary photon and proton radiation therapy. Invited. Houston, TX, US.
2013. Comparison of photon and proton therapy craniospinal irradiation. Invited. Atlanta, GA, US.
2013. Planning for cranial spinal proton radiotherapy. Invited. St. Louis, MO, US.
2011. Radiation dosimetry from treatment. Invited. Bethesda, MD, US.
2009. Secondary neutron dose from modern medical accelerators. Invited. Braunschweig, DE.

Less

Grant & Contract Support

Date:	2023 - 2024
Title:	Childhood Cancer Survivor Study (CCSS)
Funding Source:	NIH/NCI
Role:	Principal Investigator on Subcontract
ID:	3U24CA055727-29S1

Date:	2022 - 2026
Title:	Personalized Risk Prediction to Reduce Cardiovascular Disease in Childhood Cancer Survivors
Funding Source:	NIH/NCI
Role:	Multi-Principal Investigator
ID:	R01CA261750

Date:	2021 - 2026
Title:	Childhood Cancer Survivor Study (CCSS)
Funding Source:	NIH/NCI
Role:	Principal Investigator on Subcontract
ID:	U01CA246510

Date:	2021 - 2021
Title:	NO TITLE PROVIDED
Funding Source:	Princess Maxima Center for Pediatric Oncology B.V
Role:	PI
ID:	Research Service Agreement

Date:	2020 - 2025
Title:	Dosimetry for the St. Jude Lifetime Cohort
Funding Source:	St. Jude Children's Research Hospital Inc
Role:	PI
ID:	Research Service Agreement

Date:	2020 - 2021
Title:	NO TITLE PROVIDED
Funding Source:	Princess Maxima Center for Pediatric Oncology B.V
Role:	PI
ID:	Research Service Agreement

Date:	2020 - 2021
Title:	Imaging and Radiation Oncology Core - Carbon Ion Supplement
Funding Source:	American College of Radiology
Role:	Clinical Physicist
ID:	CA180803

Date:	2019 - 2020
Title:	Dosimetry for the St. Jude Lifetime Cohort
Funding Source:	St. Jude Children's Research Hospital, Inc
Role:	PI
ID:	Research Service Agreement

Date:	2019 - 2020
Title:	Marilyn and Frederick R. Lummis, Jr., M.D., Fellowship in Biomedical Sciences
Funding Source:	UT Health Graduate School of Biomedical
Role:	Advisor

Date:	2019 - 2022
Title:	Dosimetry of Therapeutic Radiation Exposure to Patient for NCI Radiation Epidemiology Branch
Funding Source:	Social & Scientific Systems, Inc
Role:	Principal Investigator-MDACC
ID:	PHR-SSS-S-19-005730

Date:	2018 - 2019
Title:	Childhood Cancer Survivor Study Career Development Trainee Grant
Funding Source:	St. Jude Children's Research Hospital
Role:	Advisor
ID:	U24 CA055727

Date:	2018 - 2019
Title:	Dosimetry of Therapeutic Radiation Exposure to Patients for NCI Radiation Epidemiology Branch
Funding Source:	Social & Scientific Systems, Inc
Role:	PI
ID:	PHR-SSS-S-18-005444 Sub-Award 2U24CA055727

Date:	2017 - 2018
Title:	Core Support Services for Medical Dosimetry for NCI Radiation Epidemiology Branch
Funding Source:	Social & Scientific Systems, Inc
Role:	PI
ID:	PHR-SSS-S-17-005241

Date:	2017 - 2021
Title:	Correcting Dose Calculation Errors in Radiation Oncology
Funding Source:	NIH/NCI
Role:	Co-I
ID:	FP00002213

Date:	2016 - 2021
Title:	Childhood Survivor Cancer Study
Funding Source:	NIH/NCI
Role:	Principal Investigator-MDACC
ID:	2U24CA055727

Date:	2016 - 2017
Title:	Core Support Services for Medical Dosimetry for NCI Radiation Epidemiology Branch
Funding Source:	Social & Scientific Systems, Inc
Role:	PI
ID:	PHR-SSS-S-15-004552

Date:	2016 - 2018
Title:	Male Fertility after Childhood Cancer
Funding Source:	Helsinki Children's Hospital
Role:	PI
ID:	Research Service Agreement

Date:	2016 - 2019
Title:	Adult Life after Childhood Cancer in Scandinavia
Funding Source:	Danish Cancer Society Research Center
Role:	PI
ID:	Research Service Agreement

Date:	2016 - 2019
Title:	Dosimetry for Dutch Childhood Oncology Group Long-Term Effects After Childhood Cancer (DCOG LATER) Cohort
Funding Source:	AMC Medical Research B.V
Role:	PI
ID:	Research Service Agreement

Date:	2015 - 2016
Title:	Core Support Services for Medical Dosimetry for NCI Radiation Epidemiology Branch
Funding Source:	Social & Scientific Systems, Inc
Role:	PI
ID:	PHR-SSS-S-15-004552

Date:	2013 - 2014
Title:	Radiation dose reconstruction methods for intensity modulated radiation therapy
Funding Source:	Childhood Cancer Survivor Study, NCI
Role:	PI
ID:	U24 C55727

Date:	2012 - 2019
Title:	Dosimetry for the St. Jude Lifetime Cohort
Funding Source:	St. Jude Children's Research Hospital, Inc
Role:	PI
ID:	Research Service Agreement

Date:	2012 - 2013
Title:	Investigation of late effects for contemporary proton and photon radiation therapy, 01/2012 to 08/2013, $37,000. Parent Grant: Northern Illinois Proton Treatment and Research Center
Funding Source:	Department of Defense (DOD)
Role:	Principal Investigator on subcontract
ID:	W81XWH-08-1-0205

Date:	2011 - 2016
Title:	Childhood Survivor Cancer Study
Funding Source:	NIH/NCI
Role:	PI
ID:	2U24CA055727 Sub: 111287180-7466326

Date:	2010 - 2011
Title:	Graduate Scholar Award
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Mentor

Date:	2008 - 2011
Title:	Improving effectiveness and accuracy of radiation therapy
Funding Source:	NIH/NCI
Role:	PI
ID:	1K01CA125204

Date:	2007
Title:	Measurement with Bonner sphere extension for high energy neutron spectroscopy (beam-time: 11 days, 24hr per day)
Funding Source:	Los Alamos Neutron Science Center
Role:	PI
ID:	20071502

Date:	2007 - 2007
Title:	Bonner sphere extension for high energy neutron spectroscopy
Funding Source:	Oak Ridge Associated Universities Ralph E. Powe Junior Faculty Award
Role:	PI

Date:	2006 - 2008
Title:	Simulation and testing of nuclear medicine hospital thyroid probes for assessing internal contamination following a radioactive dispersal device, 4/1/2007-7/31/2007, $34,000
Funding Source:	TKC Integration Services Prime (issued under Contract No. 200-2006-15969 to CDC Radiation Studies Branch)
Role:	Principle Investigator on subcontract

Date:	2005 - 2006
Title:	Effect of multileaf collimators on secondary neutron spectra from high energy medical accelerators
Funding Source:	Emory Fund for Innovative Cancer Technologies
Role:	PI

Date:	2004 - 2005
Title:	Investigation of optimal x-ray energy for IMRT for prostate cancer
Funding Source:	Georgia Cancer Coalition
Role:	PI

Selected Publications

Peer-Reviewed Articles

Veiga, LH, Gierach, GL, Smith, SA, Howell, RM, Mille, MM, Saha, M, Curtis, RE, Ramin, C, Bodelon, C, Spencer-Feigelson, H, Aiello Bowles, EJ, Buist, DS, Weinmann, S, VO, JB, Lee, C, Berrington de Gonzalez, A. Contralateral breast cancer after radiotherapy and hormone therapy in two cohorts of US breast cancer survivors. British journal of cancer 134(2):269-278, 2026. e-Pub 2026. PMID: 41238801.
Bowers, DC, Cooney, T, Chen, Y, Yuan, Y, Galvin, RT, Im, C, Leisenring, W, Brady, SW, Smith, SA, Howell, RM, Arnold, MA, Conces, MR, Yasui, Y, Diller, LR, Armstrong, GT, Neglia, JP, Turcotte, LM. Subsequent Meningiomas Among Survivors of Childhood Cancer. JAMA Network Open 8(12):e2548715, 2025. e-Pub 2025. PMID: 41379444.
Webster, RT, Srivastava, DK, Xie, L, Darji, H, Liu, W, McGrady, ME, Brinkman, TM, Alberts, NM, Ness, KK, Fuemmeler, BF, Kunin-Batson, AS, Huang, IC, Armstrong, GT, Howell, RM, Green, DM, Yasui, Y, Krull, KR. Symptom burden, healthcare utilization, and risky behaviors in survivors of the childhood cancer survivor study (CCSS). EClinicalMedicine 90, 2025. e-Pub 2025. PMID: 41340862.
Lange, KR, de Blank, P, Xing, M, Mirzaei, SS, Srivastava, DK, Oeffinger, KC, Neglia, JP, Krull, KR, Nathan, PC, Howell, RM, Ness, KK, Turcotte, LM, Leisenring, W, Armstrong, GT, Brinkman, TM, Bowers, DC, Okcu, MF. Late Morbidity and Mortality in Survivors of Childhood Ependymoma. Cancers 17(22), 2025. e-Pub 2025. PMID: 41301035.
Owens CA, Ludmir EB, Liu Q, Qiu W, Gupta AC, Smith SA, Rigaud B, Brock KK, Bates JE, Meyers TG, Paulino AC, Peterson CB, Kry SF, Teepen JC, Ronckers CM, Neglia JP, Leisenring WM, Oeffinger KC, Nathan PC, Turcotte LM, Hodgson DC, Hudson MM, Robison LL, Moskowitz CS, Armstrong GT, Henderson TO, Yasui Y, Howell RM. Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study (CCSS) Report. J Clin Oncol 43(31):3403-3421, 2025. e-Pub 2025. PMID: 41032739.
Meng X, Eulalio T, Kim Y, Easton J, Mulder HL, Walker E, Neale G, Song N, Shelton K, Howell RM, Xing M, Mirzaei S, Srivastava DK, Ky B, Dixon SB, Hudson MM, Ness KK, Armstrong GT, Wang Z. Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors. JACC CardioOncol 7(6):691-704, 2025. e-Pub 2025. PMID: 40624951.
Bhandari R, Chen Y, Chow EJ, Howell RM, Kenney LB, Krull KR, Leisenring W, Nathan PC, Neglia JP, Ness KK, Oeffinger KC, Snyder C, Turcotte LM, Wong FL, Yasui Y, Armstrong GT, Armenian SH. Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 43(27):2998-3010, 2025. e-Pub 2025. PMID: 40789102.
Lee C, Borrego D, Veiga LHS, Smith SA, Howell RM, Curtis RE, Mille MM, Feigelson HS, Weinmann S, Bowles EJA, Buist DSM, Vo JB, Gierach GL, Berrington de Gonzalez A. Trends in Dose to the Contralateral Breast from Breast Cancer Radiotherapy in the United States. Radiat Res, 2025. e-Pub 2025. PMID: 40926720.
Bashore L, Peterson RK, Li C, Liu W, Wang M, Jiwani ZM, McDonald AJ, Lupo PJ, King A, Srivastava D, Leisenring WM, Howell RM, Gibson TM, Oeffinger K, Armstrong GT, Bowman WP, Krull KR, Edelstein K. Chronic Health Conditions and Academic Achievement: A Childhood Cancer Survivor Study Report. JCO Oncol Pract:OP2500414, 2025. e-Pub 2025. PMID: 40920992.
Bolier M, Pluimakers VG, Broer L, Neggers SJ, de Winter DT, Wang F, Baedke JL, Uitterlinden AG, Petrykey K, Kremer LC, Loonen JJ, Louwerens M, van der Pal HJ, Feijen ELA, Oeffinger KC, Howell RM, Chow EJ, Leisenring WM, Gramatges MMM, Morton LM, Robison LL, Hudson MM, Ness KK, Sapkota Y, Armstrong GT, Bhatia S, Yasui Y, van den Heuvel-Eibrink MM. Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts. Cancer Epidemiol Biomarkers Prev 34(11):2068-2076, 2025. e-Pub 2025. PMID: 40853264.
Major A, Chou J, Lam H, Kim KE, Turcotte LM, Leisenring W, Yasui Y, Neglia JP, Curry M, Howell RM, Oeffinger KC, Hodgson D, Nathan PC, Armstrong GT, Moskowitz CS, Henderson TO. Mortality after colorectal cancer among survivors of childhood cancer. J Natl Cancer Inst, 2025. e-Pub 2025. PMID: 40838867.
Im C, Boull C, Lu Z, Liao K, Hasan H, Xu L, Sapkota Y, Howell RM, Arnold MA, Conces MR, Housten AJ, Gebauer J, Langer T, Teepen JC, Kremer LCM, Constine LS, Yasui Y, Hudson MM, Ness KK, Armstrong GT, Neglia JP, Yuan Y, Turcotte LM. Basal cell carcinoma risk prediction in survivors of childhood cancer. J Natl Cancer Inst 117(11):2352-2361, 2025. e-Pub 2025. PMID: 40833927.
Kenborg, L, Asdahl, PH, Bhatia, S, Christensen, J, Gudmundsdottir, T, Hjorth, L, Howell, RM, Krøyer, A, Jørgensen, M, Laursen, MR, Lassen-Ramshad, Y, de fine Licht, S, Nielsen, TT, Rechnitzer, C, Smith, SA, Wiebe, T, Hasle, H, Holmqvist, AS. Treatment-Related Risk Factors for Diabetes Mellitus in Childhood Cancer Survivors—A Case-Cohort Study Within Adult Life After Childhood Cancer in Scandinavia (ALiCCS). Pediatric Blood and Cancer 72(8), 2025. e-Pub 2025. PMID: 40399750.
Joffe L, Mirzaei S, Bhatia S, Darji H, Ness KK, Onerup A, Ladas EJ, Im C, Lupo PJ, Oeffinger KC, Friedman DN, Howell RM, Conces MR, Arnold MA, Armstrong GT, Neglia JP, Yasui Y, Kadan-Lottick NS, Turcotte LM. Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors. JAMA Oncol 11(8):835-845, 2025. e-Pub 2025. PMID: 40471634.
Petrykey K, Chen Y, Neupane A, French J, Wang H, Xiang H, Dixon SB, Vukadinovich C, Im C, Ehrhardt MJ, Mulrooney DA, Sharafeldin N, Wang X, Howell RM, Jefferies JL, Burridge PW, Oeffinger KC, Gramatges MM, Bhatia S, Robison LL, Ness KK, Hudson MM, Chow EJ, Armstrong GT, Yasui Y, Sapkota Y. Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer. Ann Oncol 36(10):1203-1211, 2025. e-Pub 2025. PMID: 40480553.
Neupane A, Liu Q, Taneja S, French J, Ehrhardt MJ, Brinkman TM, Webster R, Yang JJ, Im C, Turcotte LM, Neglia JP, Gramatges MM, Howell RM, Bhatia S, Ness KK, Hudson MM, Armstrong GT, Robison LL, Yasui Y, Sapkota Y. Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study. Lancet Oncol 26(6):806-816, 2025. e-Pub 2025. PMID: 40449499.
Galvin, RT, Chen, Y, Yuan, Y, Cooney, T, Howell, RM, Smith, SA, Arnold, MA, Conces, MR, Leisenring, W, Armstrong, GT, Neglia, JP, Turcotte, LM. Temporal trends of subsequent central nervous system malignancies among survivors of childhood cancer. Journal of the National Cancer Institute 117(5):1036-1045, 2025. e-Pub 2025. PMID: 39792043.
Edward, SS, Pollard-Larkin, JM, Balter, PA, Howell, RM, Peterson, CB, Kry, SF. IROC phantoms accurately detect MLC delivery errors. Journal of applied clinical medical physics 26(5), 2025. e-Pub 2025. PMID: 39967029.
Roberti, S, Van Leeuwen, FE, Diallo, I, De Vathaire, F, Schaapveld, M, Leisenring, W, Howell, RM, Armstrong, GT, Moskowitz, CS, Smith, SA, Aleman, BM, Krul, IM, Russell, NS, Pfeiffer, RM, Hauptmann, M. Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma. Journal of the National Cancer Institute 117(4):619-628, 2025. e-Pub 2025. PMID: 39485483.
Rotz, S, Stratton, K, Leisenring, W, Smith, SA, Howell, RM, Bates, JE, Pappo, A, Neglia, JP, Armstrong, GT, Turcotte, LM. Melanoma Among Adult Survivors of Childhood Cancer. Journal of Clinical Oncology 43(10):1219-1228, 2025. e-Pub 2025. PMID: 39778123.
Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. Characterization of LiF TLD-100 in carbon ion beams for remote audits. Medical physics 52(3):1858-1866, 2025. e-Pub 2025. PMID: 39718203.
Daniel, LC, Lubas, MM, Wang, H, Szklo-Coxe, M, Ness, KK, Williams, A, Mulrooney, DA, Howell, RM, Leisenring, W, Yasui, Y, Robison, LL, Armstrong, GT, Chow, EJ, Krull, KR, Brinkman, TM. Frailty and Sleep in Adult Survivors of Childhood Cancer. Psycho-oncology 34(2), 2025. e-Pub 2025. PMID: 39924630.
Rotz SJ, Stratton K, Leisenring WM, Smith SA, Howell RM, Bates JE, Pappo AS, Neglia JP, Armstrong GT, Turcotte LM. Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology 43(10):1219-1229, 2025. e-Pub 2025.
Hansen, HK, Asdahl, PH, Christensen, J, Pedersen, C, Krøyer, A, Pontoppidan, CS, Holmqvist, AS, Hjorth, L, Wiebe, T, Gudmundsdottir, T, de fine Licht, S, Lassen-Ramshad, Y, Seiersen, K, Jørgensen, M, Laursen, MR, Øfstaas, H, Lähteenmäki, P, Smith, SA, Howell, RM, Rechnitzer, C, Hasle, H, Winther, JF, Kenborg, L. Risk of severe esophageal stricture among childhood cancer survivors – A population-based case-cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS). EJC Paediatric Oncology 4, 2024. e-Pub 2024.
Boull, C, Chen, Y, Im, C, Geller, A, Sapkota, Y, Bates, JE, Howell, RM, Arnold, MA, Conces, MR, Constine, LS, Robison, LL, Yasui, Y, Armstrong, GT, Neglia, JP, Turcotte, LM. Keratinocyte carcinomas in survivors of childhood cancer. Journal of the American Academy of Dermatology 91(6):1125-1135, 2024. e-Pub 2024. PMID: 39182687.
Bryce Y, Whitton JA, Stratton KL, Leisenring WM, Chow EJ, Armstrong G, Weil B, Dieffenbach B, Howell RM, Oeffinger KC, Nathan PC, Tonorezos ES. Prevalence of carotid ultrasound screening in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 131(1), 2024. e-Pub 2024. PMID: 39388304.
Brooks FMD, Glenn MC, Hernandez V, Saez J, Pollard-Larkin JM, Peterson CB, Howell RM, Nelson CL, Clark CH, Kry SF. Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?. Int J Radiat Oncol Biol Phys 121(3):811-821, 2024. e-Pub 2024. PMID: 39362313.
Groarke, J, Ness, KK, Dhaduk, R, Plana, JC, Durand, J, Luepker, RV, Joshi, V, Ehrhardt, MJ, Mulrooney, DA, Dixon, SB, Nohria, A, Green, DM, Howell, RM, Srivastava, DK, Jefferies, JL, Robison, LL, Hudson, MM, Armstrong, GT. Autonomic Dysfunction Among Adult Survivors of Childhood Cancer in the St. Jude Lifetime Cohort Study. JACC: CardioOncology 6(5):775-787, 2024. e-Pub 2024. PMID: 39479326.
Ghosh T, Hyun G, Dhaduk R, Conces M, Arnold MA, Howell RM, Henderson TO, McDonald A, Robison LL, Yasui Y, Ness KK, Armstrong GT, Neglia JP, Turcotte LM. Late subsequent leukemia after childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Cancer Med 13(20):e70086, 2024. e-Pub 2024. PMID: 39431920.
Castro-Pando S, Howell RM, Li L, Mascaro M, Faraoni EY, Le Roux O, Romanin D, Tahan V, Riquelme E, Zhang Y, Kolls JK, Allison JP, Lozano G, Moghaddam SJ, McAllister F. Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis. Cancer Immunol Res 12(9):1170-1183, 2024. e-Pub 2024. PMID: 38842383.
Scott H, Alvarez PE, Howell RM, Riegel A, Sun R, Liu K, Kry SF. Chromatic bleaching and fractionation effects on optically stimulated luminescent dosimeter reuse. Med Phys 51(9):6378-6389, 2024. e-Pub 2024. PMID: 38852196.
Papini C, Mirzaei S S, Xing M, Tonning Olsson I, Salloum R, de Blank PMK, Lange KR, King TZ, Srivastava D, Leisenring WM, Howell RM, Oeffinger KC, Robison LL, Armstrong GT, Krull KR, Brinkman TM. Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over three decades. Neuro Oncol 27(1):254-266, 2024. e-Pub 2024. PMID: 38963825.
Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Vai, A, Alvarez, PE, Howell, RM, Koay, EJ, Peeler, CR, Peterson, CB, Kry, SF. Technical note. Medical physics 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
van der Plas, E, Darji, H, Srivastava, DK, Schapiro, M, Jeffe, D, Perkins, SM, Howell, RM, Leisenring, W, Armstrong, GT, Oeffinger, KC, Krull, KR, Edelstein, K, Hayashi, RJ. Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma. Cancer 130(12):2224-2236, 2024. e-Pub 2024. PMID: 38373075.
Taylor, PA, Hartzell, S, Mirandola, A, Ciocca, M, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. OSLD nanoDot characterization for carbon radiotherapy dosimetry. Physics in medicine and biology 69(11), 2024. e-Pub 2024. PMID: 38663410.
Friedman DN, Goodman PJ, Leisenring WM, Diller LR, Cohn SL, Howell RM, Smith SA, Tonorezos ES, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Turcotte LM, Weil BR, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO. Impact of risk-based therapy on late morbidity and mortality in neuroblastoma survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 116(6):885-894, 2024. e-Pub 2024. PMID: 38460547.
Bentzen, SM, Vogelius, IS, Hodgson, DC, Howell, RM, Jackson, A, Hua, CH, Olch, AJ, Ronckers, CM, Kremer, LC, Milano, MT, Marks, LB, Constine, LS. Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors. International Journal of Radiation Oncology Biology Physics 119(2):338-353, 2024. e-Pub 2024. PMID: 38760115.
Stokkevåg, CH, Journy, N, Vogelius, IS, Howell, RM, Hodgson, DC, Bentzen, SM. Radiation Therapy Technology Advances and Mitigation of Subsequent Neoplasms in Childhood Cancer Survivors. International Journal of Radiation Oncology Biology Physics 119(2):681-696, 2024. e-Pub 2024. PMID: 38430101.
Constine LS, Olch AJ, Jackson A, Hua CH, Ronckers CM, Milano MT, Marcus KJ, Yorke E, Hodgson DC, Howell RM, Hudson MM, Williams JP, Marples B, C M Kremer L, Marks LB, Bentzen SM. Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer. Int J Radiat Oncol Biol Phys 119(2):316-320, 2024. e-Pub 2021. PMID: 33810949.
Olch AJ, van Luijk P, Hua CH, Avanzo M, Howell RM, Yorke E, Aznar MC, Kry SF. Physics Considerations for Evaluation of Dose for Dose-Response Models of Pediatric Late Effects From Radiation Therapy. Int J Radiat Oncol Biol Phys 119(2):360-368, 2024. e-Pub 2023. PMID: 37003845.
Bates JE, Rancati T, Keshavarz H, Gagliardi G, Aznar MC, Howell RM, Shrestha S, Moiseenko V, Yorke E, Armenian S, Kremer L, Chen MH, van der Pal HJ, Cutter DJ, Constine LS, Hodgson D. Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 119(2):522-532, 2024. e-Pub 2023. PMID: 37061912.
Baliga, S, Patel, S, Naqa, IE, Allen Li, X, Cohen, LE, Howell, RM, Hoppe, BS, Constine, LS, Palmer, JD, Hamstra, DA, Olch, AJ. Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy. International Journal of Radiation Oncology Biology Physics 119(2):610-624, 2024. e-Pub 2024. PMID: 37791936.
Fauer, AJ, Qiu, W, Huang, IC, Ganz, PA, Casillas, J, Yabroff, KR, Armstrong, GT, Leisenring, W, Howell, RM, Howell, CR, Kirchhoff, AC, Yasui, Y, Nathan, PC. Financial hardship and neighborhood socioeconomic disadvantage in long-Term childhood cancer survivors. JNCI Cancer Spectrum 8(3), 2024. e-Pub 2024. PMID: 38676662.
Brooks, FD, Glenn, MC, Hernandez, V, Saez, J, Mehrens, H, Pollard-Larkin, JM, Howell, RM, Peterson, CB, Nelson, CL, Clark, CH, Kry, SF. A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy. Journal of applied clinical medical physics 25(5), 2024. e-Pub 2024. PMID: 38427776.
Daniel, LC, Wang, H, Brinkman, TM, Ruble, K, Zhou, ES, Palesh, O, Stremler, R, Howell, RM, Mulrooney, DA, Crabtree, VM, Mostoufi-Moab, S, Oeffinger, KC, Neglia, JP, Yasui, Y, Armstrong, GT, Krull, KR. Mechanisms of sleep disturbances in long-term cancer survivors. JNCI Cancer Spectrum 8(2), 2024. e-Pub 2024. PMID: 38366608.
Dixon, SB, Wang, F, Lu, L, Wilson, CL, Green, DM, Merchant, TE, Srivastava, DK, Delaney, A, Howell, RM, Jefferies, JL, Robison, LL, Ness, KK, Hudson, MM, Chemaitilly, W, Armstrong, GT. Prediabetes and Associated Risk of Cardiovascular Events and Chronic Kidney Disease Among Adult Survivors of Childhood Cancer in the St Jude Lifetime Cohort. Journal of Clinical Oncology 42(9):1031-1043, 2024. e-Pub 2024. PMID: 38091552.
Gibson, TM, Karyadi, DM, Hartley, SW, Arnold, MA, Berrington De Gonzalez, A, Conces, MR, Howell, RM, Kapoor, V, Leisenring, W, Neglia, JP, Sampson, JN, Turcotte, LM, Chanock, S, Armstrong, GT, Morton, LM. Polygenic risk scores, radiation treatment exposures and subsequent cancer risk in childhood cancer survivors. Nature medicine 30(3):690-698, 2024. e-Pub 2024. PMID: 38454124.
Bottinor, W, Im, C, Doody, DR, Armenian, SH, Arynchyn, A, Hong, B, Howell, RM, Jacobs, Dr, Ness, KK, Oeffinger, KC, Reiner, AP, Armstrong, GT, Yasui, Y, Chow, EJ. Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer. Journal of the American College of Cardiology 83(8):827-838, 2024. e-Pub 2024. PMID: 38383098.
Scott, H, Alvarez, PE, Howell, RM, Riegel, AC, Sun, R, Kry, SF. Lifetime extension of optically stimulated luminescent dosimeters above 10 gy. Radiation Measurements 171, 2024. e-Pub 2024.
Vuotto, SC, Wang, M, Okcu, MF, Bowers, DC, Ullrich, NJ, Ness, KK, Li, C, Srivastava, DK, Howell, RM, Gibson, TM, Leisenring, W, Oeffinger, KC, Robison, LL, Armstrong, GT, Krull, KR, Brinkman, TM. Neurologic morbidity and functional independence in adult survivors of childhood cancer. Annals of Clinical and Translational Neurology 11(2):291-301, 2024. e-Pub 2024. PMID: 38013658.
Papini C, Mirzaei S, Xing M, Tonning Olsson I, de Blank P, Lange KR, Salloum R, Srivastava D, Leisenring WM, Howell RM, Oeffinger KC, Robison LL, Armstrong GT, Krull KR, Brinkman TM. Evolving therapies, neurocognitive outcomes and functional independence in adult survivors of childhood glioma. J Natl Cancer Inst 116(2):288-298, 2024. e-Pub 2023. PMID: 37688569.
Im, C, Lu, Z, Mostoufi-Moab, S, Delaney, A, Yu, L, Baedke, JL, Han, Y, Sapkota, Y, Yasui, Y, Chow, EJ, Howell, RM, Bhatia, S, Hudson, MM, Ness, KK, Armstrong, GT, Nathan, PC, Yuan, Y. Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer. The lancet oncology 24(12):1434-1442, 2023. e-Pub 2023. PMID: 37972608.
Wilson CL, Bjornard KL, Partin RE, Kadan-Lottick NS, Nathan PC, Oeffinger KC, Hayashi RJ, Hyun G, Armstrong GT, Leisenring WM, Howell RM, Yasui Y, Dixon SB, Ehrhardt MJ, Robison LL, Ness KK. Trends in physical functioning in acute lymphoblastic leukemia and non-Hodgkin lymphoma survivors across three decades. J Cancer Surviv 19(2):496-506, 2023. e-Pub 2023. PMID: 37938431.
Gronberg MP, Jhingran A, Netherton TJ, Gay SS, Cardenas CE, Chung C, Fuentes D, Fuller CD, Howell RM, Khan M, Lim TY, Marquez B, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep learning-based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Med Phys 50(11):6639-6648, 2023. e-Pub 2023. PMID: 37706560.
Chen, C, Qin, N, Wang, M, Dong, Q, Tithi, SS, Hui, Y, Chen, W, Wu, G, Kennetz, D, Edmonson, M, Rusch, MC, Thrasher, A, Easton, J, Mulder, HL, Song, N, Plonski, NM, Shelton, K, Im, C, Ehrhardt, MJ, Nichols, KE, Leisenring, W, Stratton, K, Howell, RM, Yasui, Y, Bhatia, S, Armstrong, GT, Ness, KK, Hudson, MM, Zhang, J, Wang, H, Srivastava, DK, Robison, LL, Wang, Z. Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors. The lancet oncology 24(10):1147-1156, 2023. e-Pub 2023. PMID: 37797633.
Belle, FN, Schindera, C, Ansari, M, Armstrong, GT, Beck-Popovic, M, Howell, RM, Leisenring, W, Meacham, LR, Ros̈sler, J, Spycher, BD, Tonorezos, ES, Von Der Weid, N, Yasui, Y, Oeffinger, KC, Kuehni, CE. Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland. Cancer medicine 12(20):20423-20436, 2023. e-Pub 2023. PMID: 37807946.
Watt GP, Smith SA, Howell RM, Pérez-Andújar A, Reiner AS, Cerviño L, McCormick B, Hess D, Knight JA, Malone KE, John EM, Bernstein L, Lynch CF, Mellemkjær L, Shore RE, Liang X, Woods M, Boice JD, Dauer LT, Bernstein JL. Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy. Radiat Res 200(4):331-339, 2023. e-Pub 2023. PMID: 37590492.
Wang, Y, Ronckers, CM, Van Leeuwen, FE, Moskowitz, CS, Leisenring, W, Armstrong, GT, De Vathaire, F, Hudson, MM, Kuehni, CE, Arnold, MA, Demoor-Goldschmidt, C, Green, DM, Henderson, TO, Howell, RM, Ehrhardt, MJ, Neglia, JP, Oeffinger, KC, Van Der Pal, HJ, Robison, LL, Schaapveld, M, Turcotte, LM, Waespe, N, Kremer, LC, Teepen, JC, Van Leeuwen, FE, De Vathaire, F, Van Der Pal, HJ, Haddy, N, Diallo, I, Baker, KS, de González, AB, Conces, MR, Constine, LS, Hawkins, MM, Loonen, JJ, Louwerens, M, Janssens, GO, Mellemkjaer, L, Reulen, RC, Winther, JF. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer. Nature medicine 29(9):2268-2277, 2023. e-Pub 2023. PMID: 37696934.
Hesko C, Liu W, Srivastava DK, Brinkman TM, Diller L, Gibson TM, Oeffinger KC, Leisenring WM, Howell R, Armstrong GT, Krull KR, Henderson TO. Neurocognitive outcomes in adult survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 129(18):2904-2914, 2023. e-Pub 2023. PMID: 37199722.
Im C, Sharafeldin N, Yuan Y, Wang Z, Sapkota Y, Lu Z, Spector LG, Howell RM, Arnold MA, Hudson MM, Ness KK, Robison LL, Bhatia S, Armstrong GT, Neglia JP, Yasui Y, Turcotte LM. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report. J Clin Oncol 41(27):4381-4393, 2023. e-Pub 2023. PMID: 37459583.
Baliga S, Patel S, El Naqa I, Li XA, Cohen LE, Howell RM, Hoppe BS, Constine LS, Palmer JD, Hamstra D, Olch AJ. Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology, Biology, Physics 119(2):610-624, 2023. e-Pub 2023.
Bates JE, Shrestha S, Liu Q, Smith SA, Mulrooney DA, Leisenring W, Gibson T, Robison LL, Chow EJ, Oeffinger KC, Armstrong GT, Constine LS, Hoppe BS, Lee C, Yasui Y, Howell RM. Cardiac Substructure Radiation Dose and Risk of Late Cardiac Disease in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 41(22):3826-3838, 2023. e-Pub 2023. PMID: 37307512.
Noyd DH, Liu Q, Yasui Y, Chow EJ, Bhatia S, Nathan PC, Landstrom AP, Tonorezos E, Casillas J, Berkman A, Ness KK, Mulrooney DA, Leisenring WM, Howell CR, Shoag J, Kirchhoff A, Howell RM, Gibson TM, Zullig LL, Armstrong GT, Oeffinger KC. Cardiovascular Risk Factor Disparities in Adult Survivors of Childhood Cancer Compared With the General Population. JACC CardioOncol 5(4):489-500, 2023. e-Pub 2023. PMID: 37614575.
Esbenshade AJ, Lu L, Friedman DL, Oeffinger KC, Armstrong GT, Krull KR, Neglia JP, Leisenring WM, Howell R, Partin R, Sketch A, Robison LL, Ness KK. Accumulation of Chronic Disease Among Survivors of Childhood Cancer Predicts Early Mortality. J Clin Oncol 41(20):3629-3641, 2023. e-Pub 2023. PMID: 37216619.
Hernandez S, Nguyen C, Gay S, Duryea J, Howell R, Fuentes D, Parkes J, Burger H, Cardenas C, Paulino AC, Pollard-Larkin J, Court L. Resection cavity auto-contouring for patients with pediatric medulloblastoma using only CT information. J Appl Clin Med Phys 24(7):e13956, 2023. e-Pub 2023. PMID: 36917640.
Dieffenbach BV, Murphy AJ, Liu Q, Ramsey DC, Geiger EJ, Diller LR, Howell RM, Oeffinger KC, Robison LL, Yasui Y, Armstrong GT, Chow EJ, Weil BR, Weldon CB. Cumulative burden of late, major surgical intervention in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study (CCSS) cohort. Lancet Oncol 24(6):691-700, 2023. e-Pub 2023. PMID: 37182536.
Weil BR, Murphy AJ, Liu Q, Howell RM, Smith SA, Weldon CB, Mullen EA, Madenci AL, Leisenring WM, Neglia JP, Turcotte LM, Oeffinger KC, Termuhlen AM, Mostoufi-Moab S, Levine JM, Krull KR, Yasui Y, Robison LL, Armstrong GT, Chow EJ, Armenian SH. Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 41(14):2638-2650, 2023. e-Pub 2023. PMID: 36693221.
Mehrens H, Molineu A, Hernandez N, Court L, Howell R, Jaffray D, Peterson CB, Pollard-Larkin J, Kry SF. Characterizing the interplay of treatment parameters and complexity and their impact on performance on an IROC IMRT phantom using machine learning. Radiother Oncol 182:109577, 2023. e-Pub 2023. PMID: 36841341.
Phillips NS, Stratton KL, Williams AM, Ahles T, Ness KK, Cohen HJ, Edelstein K, Yasui Y, Oeffinger K, Chow EJ, Howell RM, Robison LL, Armstrong GT, Leisenring WM, Krull KR. Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors. JAMA Netw Open 6(5):e2316077, 2023. e-Pub 2023. PMID: 37256617.
Wu NL, Chen Y, Dieffenbach BV, Ehrhardt MJ, Hingorani S, Howell RM, Jefferies JL, Mulrooney DA, Oeffinger KC, Robison LL, Weil BR, Yuan Y, Yasui Y, Hudson MM, Leisenring WM, Armstrong GT, Chow EJ. Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer. J Clin Oncol 41(12):2258-2268, 2023. e-Pub 2023. PMID: 36795981.
Dixon SB, Liu Q, Chow EJ, Oeffinger KC, Nathan PC, Howell RM, Leisenring WM, Ehrhardt MJ, Ness KK, Krull KR, Mertens AC, Hudson MM, Robison LL, Yasui Y, Armstrong GT. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 401(10386):1447-1457, 2023. e-Pub 2023. PMID: 37030315.
Papini C, Fayad AA, Wang M, Schulte FSM, Huang IC, Chang YP, Howell RM, Srivastava D, Leisenring WM, Armstrong GT, Gibson TM, Robison LL, Oeffinger KC, Krull KR, Brinkman TM. Emotional, behavioral, and physical health consequences of loneliness in young adult survivors of childhood cancer: Results from the Childhood Cancer Survivor Study. Cancer 129(7):1117-1128, 2023. e-Pub 2023. PMID: 36645710.
Olch AJ, van Luijk P, Hua CH, Avanzo M, Howell RM, Yorke E, Aznar MC, Kry SF. Physics Considerations for Evaluation of Dose for Dose-Response Models of Pediatric Late Effects From Radiation Therapy: A PENTEC Introductory Review. International Journal of Radiation Oncology, Biology, Physics 119(2):360-368, 2023. e-Pub 2023.
Friedman DN, Goodman PJ, Leisenring WM, Diller LR, Cohn SL, Howell RM, Smith SA, Tonorezos ES, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Weil BR, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO. Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 41(8):1565-1576, 2023. e-Pub 2023. PMID: 36525618.
Hernandez S, Nguyen C, Parkes J, Burger H, Rhee DJ, Netherton T, Mumme R, Vega JG, Duryea J, Leone A, Paulino AC, Cardenas C, Howell R, Fuentes D, Pollard-Larkin J, Court L. Automating the treatment planning process for 3D-conformal pediatric craniospinal irradiation therapy. Pediatr Blood Cancer 70(3):e30164, 2023. e-Pub 2023. PMID: 36591994.
Geiger EJ, Liu W, Srivastava DK, Bernthal NM, Weil BR, Yasui Y, Ness KK, Krull KR, Goldsby RE, Oeffinger KC, Robison LL, Dieffenbach BV, Weldon CB, Gebhardt MC, Howell R, Murphy AJ, Leisenring WM, Armstrong GT, Chow EJ, Wustrack RL. What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report. Clin Orthop Relat Res 481(3):526-538, 2023. e-Pub 2023. PMID: 35583517.
Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, Oeffinger KC, Moskowitz CS, Henderson TO, Mertens A, Nathan PC, Yasui Y, Landier W, Armstrong GT, Robison LL, Bhatia S. Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors. J Clin Oncol 41(5):JCO2200574, 2023. e-Pub 2023. PMID: 36265088.
Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CA, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep Learning–Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. International Journal of Radiation Oncology, Biology, Physics 13(3):e282-e291, 2023.
Turcotte LM, Whitton JA, Leisenring WM, Howell RM, Neglia JP, Phelan R, Oeffinger KC, Ness KK, Woods WG, Kolb EA, Robison LL, Armstrong GT, Chow EJ. Chronic conditions, late mortality, and health status after childhood AML: a Childhood Cancer Survivor Study report. Blood 141(1):90-101, 2023. e-Pub 2023. PMID: 36037430.
Hernandez S, Burger H, Nguyen C, Paulino AC, Lucas JT, Faught AM, Duryea J, Netherton T, Rhee DJ, Cardenas C, Howell R, Fuentes D, Pollard-Larkin J, Court L, Parkes J. Validation of an automated contouring and treatment planning tool for pediatric craniospinal radiation therapy. Front Oncol 13:1221792, 2023. e-Pub 2023. PMID: 37810961.
Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CE, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol 13(3):e282-e291, 2023. e-Pub 2023. PMID: 36697347.
Henderson TO, Liu Q, Turcotte LM, Neglia JP, Leisenring W, Hodgson D, Diller L, Kenney L, Morton L, Berrington de Gonzalez A, Arnold M, Bhatia S, Howell RM, Smith SA, Robison LL, Armstrong GT, Oeffinger KC, Yasui Y, Moskowitz CS. Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors: A Report From the Childhood Cancer Survivor Study (CCSS). JAMA Oncol 8(12):1765-1774, 2022. e-Pub 2022. PMID: 36227603.
Richard MA, Mostoufi-Moab S, Rathore N, Baedke J, Brown AL, Chanock SJ, Friedman DN, Gramatges MM, Howell RM, Kamdar KY, Leisenring WM, Meacham LR, Morton LM, Oeffinger K, Robison LL, Sapkota Y, Sklar CA, Armstrong GT, Bhatia S, Lupo PJ. Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts. JCO Precis Oncol 6:e2200239, 2022. e-Pub 2022. PMID: 36480781.
Wang Y, Kremer LCM, van Leeuwen FE, Armstrong GT, Leisenring W, de Vathaire F, Hudson MM, Kuehni CE, Arnold MA, Haddy N, Demoor-Goldschmidt C, Diallo I, Howell RM, Ehrhardt MJ, Moskowitz CS, Neglia JP, van der Pal HJH, Robison LL, Schaapveld M, Turcotte LM, Waespe N, Ronckers CM, Teepen JC, after Childhood ICFPSOSM, Cancer A. Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort. BMJ Open 12(11):e065910, 2022. e-Pub 2022. PMID: 36344003.
Owens CA, Rigaud B, Ludmir EB, Gupta AC, Shrestha S, Paulino AC, Smith SA, Peterson CB, Kry SF, Lee C, Henderson TO, Armstrong GT, Brock KK, Howell RM. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol 176:118-126, 2022. e-Pub 2022. PMID: 36063983.
Netherton TJ, Nguyen C, Cardenas CE, Chung C, Klopp AH, Colbert LE, Rhee DJ, Peterson CB, Howell R, Balter P, Court LE. An Automated Treatment Planning Framework for Spinal Radiation Therapy and Vertebral-Level Second Check. Int J Radiat Oncol Biol Phys 114(3):516-528, 2022. e-Pub 2022. PMID: 35787928.
Burmeister JW, Busse NC, Cetnar AJ, Howell R, Jeraj R, Jones AK, King SH, Matthews KL, Montemayor VJ, Newhauser W, Rodrigues AE, Samei E, Turkington TV, Gronberg MP, Loughery B, Roth AR, Joiner MC, Jackson EF, Naine PA, Kim LH. Academic program recommendations for graduate degrees in medical physics: AAPM Report No. 365 (Revision of Report No. 197). J Appl Clin Med Phys 23(10):e13792, 2022. e-Pub 2022. PMID: 36208145.
Want Z, Virgolin M, Balgobind BV, IWEM VD, Smith SA, Howell RM, Mille MM, Lee C, Ronckers CM, Bosman PAN, Bel A, Alderliesten T. Validation and Comparison of Radiograph-Based Organ Dose Reconstruction Approaches for Wilms Tumor Radiation Treatment Plans. Advances in Radiation Oncology 2022(7), 2022. e-Pub 2022.
Williams AM, Mirzaei Salehabadi S, Xing M, Phillips NS, Ehrhardt MJ, Howell R, Yasui Y, Oeffinger KC, Gibson T, Chow EJ, Leisenring W, Srivastava D, Hudson MM, Robison LL, Armstrong GT, Krull KR. Modifiable risk factors for neurocognitive and psychosocial problems after Hodgkin lymphoma. Blood 139(20):3073-3086, 2022. e-Pub 2022. PMID: 34861035.
Gupta AC, Owens CA, Shrestha S, Lee C, Smith SA, Weathers RE, Netherton T, Balter PA, Kry SF, Followill DS, Griffin KT, Long JP, Armstrong GT, Howell RM. Body region-specific 3D age-scaling functions for scaling whole-body computed tomography anatomy for pediatric late effects studies. Biomed Phys Eng Express 8(2), 2022. e-Pub 2022. PMID: 34874300.
Chemaitilly W, Li Z, Brinkman TM, Delaney A, Huang S, Bjornard KL, Lam CG, Wilson CL, Barnes N, Clark KL, Krasin MJ, Metzger ML, Sheyn A, Bishop MW, Sabin ND, Howell RM, Helmig S, Shulkin BL, Triplett BM, Pui CH, Gajjar A, Srivastava DK, Green DM, Armstrong GT, Robison LL, Hudson MM, Ness KK, Sklar CA, Krull KR. Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequences. Cancer 128(3):606-614, 2022. e-Pub 2022. PMID: 34643950.
Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, Kadan-Lottick NS, Krull KR, Oeffinger KC, Neglia JP, Hudson MM, Robison LL, Mertens AC, Armstrong GT, Nathan PC. Impact of risk-stratified therapy on health status in survivors of childhood Acute Lymphoblastic Leukemia: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 31(1):150-160, 2022. e-Pub 2022. PMID: 34697055.
Glenn MC, Brooks F, Peterson CB, Howell RM, Followill DS, Pollard-Larkin JM, Kry SF. Photon beam modeling variations predict errors in IMRT dosimetry audits. Radiother Oncol 166:8-14, 2022. e-Pub 2022. PMID: 34748857.
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. The radiotherapy quality assurance gap among phase III cancer clinical trials. Radiother Oncol 166:51-57, 2022. e-Pub 2022. PMID: 34838891.
Henderson TO, Fowler BW, Hamann HA, Nathan PC, Whitton J, Leisenring WM, Oeffinger KC, Neglia JP, Turcotte LM, Arnold MA, Conces MR, Howell RM, Robison LL, Armstrong GT, Alexander KA. Subsequent malignant neoplasms in the childhood cancer survivor study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor. Cancer 128(2):373-382, 2022. e-Pub 2022. PMID: 34606625.
Wang Z, Virgolin M, Balgobind BV, IWEM VD, Smith SA, Howell RM, Mille MM, Lee C, Lee C, Ronckers CM, Bosman PAN, Bel A, Alderliesten T. Validation and Comparison of Radiograph-Based Organ Dose Reconstruction Approaches for Wilms Tumor Radiation Treatment Plans. Adv Radiat Oncol 7(6):101015, 2022. e-Pub 2022. PMID: 36060631.
Jefferies JL, Mazur WM, Howell CR, Plana JC, Ness KK, Li Z, Joshi VM, Green DM, Mulrooney DA, Towbin JA, Martinez HR, Goldberg JF, Howell RM, Srivastava DK, Robison LL, Hudson MM, Armstrong GT. Cardiac remodeling after anthracycline and radiotherapy exposure in adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Cancer 127(24):4646-4655, 2021. e-Pub 2021. PMID: 34411296.
Sato S, Li N, Dixon SB, Kato M, Zhang H, Li CK, Howell RM, Leisenring WM, Bhatia S, Oeffinger KC, Armstrong GT, Yasui Y, Krull KR, Cheung YT. Functional Outcomes and Social Attainment in Asian/Pacific Islander Childhood Cancer Survivors in the United States: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 30(12):2244-2255, 2021. e-Pub 2021. PMID: 34607839.
Ghosh T, Chen Y, Dietz AC, Armstrong GT, Howell RM, Smith SA, Mulrooney DA, Turcotte LM, Yuan Y, Yasui Y, Neglia JP. Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer. Cancer Epidemiol Biomarkers Prev 30(12):2235-2243, 2021. e-Pub 2021. PMID: 34526300.
Trendowski MR, Baedke JL, Sapkota Y, Travis LB, Zhang X, El Charif O, Wheeler HE, Leisenring WM, Robison LL, Hudson MM, Morton LM, Oeffinger KC, Howell RM, Armstrong GT, Bhatia S, Dolan ME. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort. Cancer 127(21):4091-4102, 2021. e-Pub 2021. PMID: 34286861.
Lo AC, Ronckers C, Aznar MC, Avanzo M, van Dijk I, Kremer LCM, Gagliardi G, Howell RM, Rancati T, Constine LS, Marcus KJ. Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 21(2):549-559, 2021. e-Pub 2021. PMID: 34627655.
Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol 163:199-208, 2021. e-Pub 2021. PMID: 34454975.
Moskowitz CS, Ronckers CM, Chou JF, Smith SA, Friedman DN, Barnea D, Kok JL, de Vries S, Wolden SL, Henderson TO, van der Pal HJH, Kremer LCM, Neglia JP, Turcotte LM, Howell RM, Arnold MA, Schaapveld M, Aleman B, Janus C, Versluys B, Leisenring W, Sklar CA, Begg CB, Pike MC, Armstrong GT, Robison LL, van Leeuwen FE, Oeffinger KC. Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts. J Clin Oncol 39(27):3012-3021, 2021. e-Pub 2021. PMID: 34048292.
Carlson LE, Watt GP, Tonorezos ES, Chow EJ, Yu AF, Woods M, Lynch CF, John EM, Mellemkj?r L, Brooks JD, Knight JA, Reiner AS, Liang X, Smith SA, Bernstein L, Dauer LT, Cerviño LI, Howell RM, Shore RE, Boice JD, Bernstein JL, Collaborative Group WS. Coronary Artery Disease in Young Women After Radiation Therapy for Breast Cancer: The WECARE Study. JACC CardioOncol 3(3):381-392, 2021. e-Pub 2021. PMID: 34604798.
Dieffenbach BV, Liu Q, Murphy AJ, Stein DR, Wu N, Madenci AL, Leisenring WM, Kadan-Lottick NS, Christison-Lagay ER, Goldsby RE, Howell RM, Smith SA, Oeffinger KC, Yasui Y, Armstrong GT, Weldon CB, Chow EJ, Weil BR. Late-onset kidney failure in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer 155:216-226, 2021. e-Pub 2021. PMID: 34391054.
Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS. Longitudinal Evaluation of Neuromuscular Dysfunction in Long-term Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 30(8):1536-1545, 2021. e-Pub 2021. PMID: 34099519.
Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO, Howell RM, Wolden SL, Constine LS, Diller LR, Sklar CA, Nathan PC, Castellino SM, Barnea D, Smith SA, Hutchinson RJ, Armstrong GT, Robison LL. Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 39(20):2266-2275, 2021. e-Pub 2021. PMID: 33630659.
Allodji RS, Tucker MA, Hawkins MM, Le Deley MC, Veres C, Weathers R, Howell R, Winter D, Haddy N, Rubino C, Diallo I, Little MP, Morton LM, de Vathaire F. Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: An international pooled analysis. Int J Cancer 148(9):2079-2089, 2021. e-Pub 2021. PMID: 33105035.
Im C, Li N, Moon W, Liu Q, Morton LM, Leisenring WM, Howell RM, Chow EJ, Sklar CA, Wilson CL, Wang Z, Sapkota Y, Chemaitilly W, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y. Genome-wide Association Studies Reveal Novel Locus With Sex-/Therapy-Specific Fracture Risk Effects in Childhood Cancer Survivors. J Bone Miner Res 36(4):685-695, 2021. e-Pub 2020. PMID: 33338273.
Stefanski KJ, Anixt JS, Goodman P, Bowers K, Leisenring W, Scott Baker K, Burns K, Howell R, Davies S, Robison LL, Armstrong GT, Krull KR, Recklitis C. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. J Natl Cancer Inst 113(4):481-495, 2021. e-Pub 2021. PMID: 32797189.
Güntürkün F, Akbilgic O, Davis RL, Armstrong GT, Howell RM, Jefferies JL, Ness KK, Karabayir I, Lucas JT, Srivastava DK, Hudson MM, Robison LL, Soliman EZ, Mulrooney DA. Artificial Intelligence-Assisted Prediction of Late-Onset Cardiomyopathy Among Childhood Cancer Survivors. JCO Clin Cancer Inform 5:459-468, 2021. e-Pub 2021. PMID: 33909450.
Foster RH, Hayashi RJ, Wang M, Liu W, Mohrmann C, Howell RM, Smith SA, Gibson TM, Srivastava D, Green DM, Oeffinger KC, Leisenring WM, Robison LL, Armstrong GT, Krull KR, Hardy KK. Psychological, educational, and social late effects in adolescent survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study. Psychooncology 30(3):349-360, 2021. e-Pub 2020. PMID: 33113206.
Dixon SB, Howell CR, Lu L, Plana JC, Joshi VM, Luepker RV, Durand JB, Ky B, Lenihan DJ, Jefferies JL, Green DM, Ehrhardt MJ, Mulrooney DA, Folse TE, Partin RE, Santucci AK, Howell RM, Srivastava DK, Hudson MM, Robison LL, Ness KK, Armstrong GT. Cardiac biomarkers and association with subsequent cardiomyopathy and mortality among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort. Cancer 127(3):458-466, 2021. e-Pub 2020. PMID: 33108003.
Lubas MM, Wang M, Jefferies JL, Ness KK, Ehrhardt MJ, Krull KR, Mulrooney DA, Srivastava DK, Howell RM, Robison LL, Hudson MM, Armstrong GT, Brinkman TM. The Contribution of Stress and Distress to Cardiovascular Health in Adult Survivors of Childhood Cancer. Cancer Epidemiol Biomarkers Prev 30(2):286-294, 2021. e-Pub 2021. PMID: 33234555.
Goldberg JF, Ness KK, Chi X, Santucci AK, Plana JC, Joshi VM, Luepker RV, Durand JB, Partin RE, Howell RM, Wilson CL, Towbin JA, Jefferies JL, Srivastava DK, Hudson MM, Robison LL, Armstrong GT. Cardiovascular Family History Increases Risk for Late-Onset Adverse Cardiovascular Outcomes in Childhood Cancer Survivors: A St. Jude Lifetime Cohort Report. Cancer Epidemiol Biomarkers Prev 30(1):123-132, 2021. e-Pub 2020. PMID: 33033146.
Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020. PMID: 33459402.
de Blank P, Li N, Fisher MJ, Ullrich NJ, Bhatia S, Yasui Y, Sklar CA, Leisenring W, Howell R, Oeffinger K, Hardy K, Okcu MF, Gibson TM, Robison LL, Armstrong GT, Krull KR. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genet Med 22(11):1794-1802, 2020. e-Pub 2020. PMID: 32572180.
Williams AM, Xing M, Salehabadi SM, Yasui Y, Ehrhardt MJ, Howell RM, Oeffinger KC, Gibson T, Chow E, Leisenring W, Srivastava D, Robison LL, Armstrong GT, Krull KR. Prevalence and Predictors of Neurocognitive Impairment in Long-Term Survivors of Childhood Hodgkin Lymphoma: A Report from the Childhood Cancer Survivor Study. Blood 136:14-15, 2020. e-Pub 2020.
Gupta AC, Shrestha S, Owens CA, Smith SA, Qiao Y, Weathers RE, Balter PA, Kry SF, Howell RM. Development of an age-scalable 3D computational phantom in DICOM standard for late effects studies of childhood cancer survivors. Biomed Phys Eng Express 6(6), 2020. e-Pub 2020. PMID: 34584772.
Shrestha S, Gupta AC, Bates JE, Lee C, Owens CA, Hoppe BS, Constine LS, Smith SA, Qiao Y, Weathers RE, Yasui Y, Court LE, Paulino AC, Pinnix CC, Kry SF, Followill DS, Armstrong GT, Howell RM. Development and Validation of an Age-Scalable Cardiac Model with Substructures for Dosimetry in Late-Effects Studies of Childhood Cancer Survivors. Radiother Oncol. e-Pub 2020. PMID: 33075392.
Cheung YT, Liu W, Brinkman TM, Srivastava D, Leisenring WM, Howell RM, Ullrich NJ, Lommel KM, Brouwers P, Gibson TM, Robison LL, Armstrong GT, Krull KR. Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer and Association With Adult Functional Outcomes. JNCI Cancer Spectr 4(5):pkaa057, 2020. e-Pub 2020. PMID: 33134833.
Glenn MC, Peterson CB, Howell RM, Followill DS, Pollard-Larkin JM, Kry SF. Sensitivity of IROC phantom performance to radiotherapy treatment planning system beam modeling parameters based on community-driven data. Med Phys 47(10):5250-5259, 2020. e-Pub 2020. PMID: 32677052.
Edward SS, Glenn M, Peterson CB, Balter PA, Pollard-Larkin JM, Howell RM, Followill D, Kry SF. Dose calculation errors as a component of failing IROC lung and spine phantom irradiations. Med Phys 47(9):4502-4508, 2020. e-Pub 2020. PMID: 32452027.
Baltz GC, Briere T, Luo D, Howell RM, Krafft S, Han EY. 3D-printed headrest for frameless Gamma Knife radiosurgery: Design and validation. J Appl Clin Med Phys 21(9):6-15, 2020. e-Pub 2020. PMID: 32603542.
Gupta AC, Shrestha S, Owens CA, Smith, SA, Qiao Y, Weathers RE, Balter PA, Kry SF, Howell RM. Development of an Age-scalable 3D Computational Phantom in DICOM Standard for Late Effects Studies of Childhood Cancer Survivors. Biomed. Phys. Eng. Express 6(6), 2020. e-Pub 2020.
Ntentas G, Darby SC, Aznar MC, Hodgson DC, Howell RM, Maraldo MV, Ahmed S, Ng A, Aleman BMP, Cutter DJ. Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction. Radiother Oncol. e-Pub 2020. PMID: 32890611.
Kisling K, Cardenas C, Anderson BM, Zhang J, Jhingran A, Simonds H, Balter P, Howell RM, Schmeler K, Beadle BM, Court L. Automatic verification of beam apertures for cervical cancer radiotherapy. Pract Radiat Oncol 10(5):e415-e424, 2020. e-Pub 2020. PMID: 32450365.
Morton LM, Karyadi DM, Hartley SW, Frone MN, Sampson JN, Howell RM, Neglia JP, Arnold MA, Hicks BD, Jones K, Zhu B, Dagnall CL, Karlins E, Yeager MS, Leisenring WM, Yasui Y, Turcotte LM, Smith SA, Weathers RE, Miller J, Sigel BS, Merino DM, Berrington de Gonzalez A, Bhatia S, Robison LL, Tucker MA, Armstrong GT, Chanock SJ. Subsequent Neoplasm Risk Associated With Rare Variants in DNA Damage Response and Clinical Radiation Sensitivity Syndrome Genes in the Childhood Cancer Survivor Study. JCO Precis Oncol 4, 2020. e-Pub 2020. PMID: 32923912.
Wilson CL, Liu W, Chemaitilly W, Howell CR, Srivastava DK, Howell RM, Hudson MM, Robison LL, Ness KK. Body Composition, Metabolic Health, and Functional Impairment among Adults Treated for Abdominal and Pelvic Tumors during Childhood. Cancer Epidemiol Biomarkers Prev. e-Pub 2020. PMID: 32796078.
Ehrhardt MJ, Ward ZJ, Liu Q, Chaudhry A, Nohria A, Border W, Fulbright JM, Mulrooney DA, Oeffinger KC, Nathan PC, Leisenring WM, Constine LS, Gibson TM, Chow EJ, Howell RM, Robison LL, Armstrong GT, Hudson MM, Diller L, Yasui Y, Armenian SH, Yeh JM. Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer. J Clin Oncol:JCO2000418. e-Pub 2020. PMID: 32795226.
Dieffenbach BV, Li N, Madenci AL, Murphy AJ, Barnea D, Gibson TM, Tonorezos ES, Leisenring WM, Howell RM, Diller LR, Liu Q, Chow EJ, Armstrong GT, Yasui Y, Oeffinger KC, Weldon CB, Weil BR. Incidence of and risk factors for late cholecystectomy in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Eur J Cancer 133:4-13, 2020. e-Pub 2020. PMID: 32422507.
Dixon SB, Chen Y, Yasui Y, Pui CH, Hunger SP, Silverman LB, Ness KK, Green DM, Howell RM, Leisenring WM, Kadan-Lottick NS, Krull KR, Oeffinger KC, Neglia JP, Mertens AC, Hudson MM, Robison LL, Armstrong GT, Nathan PC. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study. J Clin Oncol:JCO2000493. e-Pub 2020. PMID: 32706634.
Journy N, Schonfeld SJ, Hauptmann M, Roberti S, Howell RM, Smith SA, Vaalavirta L, Stovall M, van Leeuwen FE, Weathers RE, Hodgson D, Gilbert ES, Berrington de Gonzalez A, Morton LM. Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. Radiother Oncol. e-Pub 2020. PMID: 32679305.
Barlow-Krelina E, Chen Y, Yasui Y, Till C, Gibson TM, Ness KK, Leisenring WM, Howell RM, Nathan PC, Oeffinger KC, Robison LL, Armstrong GT, Krull KR, Edelstein K. Consistent Physical Activity and Future Neurocognitive Problems in Adult Survivors of Childhood Cancers: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 38(18):2041-2052, 2020. e-Pub 2020. PMID: 32330104.
Karlson CW, Alberts NM, Liu W, Brinkman TM, Annett RD, Mulrooney DA, Schulte F, Leisenring WM, Gibson TM, Howell RM, Srivastava D, Oeffinger KC, Robison LL, Armstrong GT, Zeltzer LK, Krull KR. Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 126(12):2915-2923, 2020. e-Pub 2020. PMID: 32227649.
Hayek S, Brinkman TM, Plana JC, Joshi VM, Leupker RV, Durand JB, Green DM, Partin RE, Santucci AK, Howell RM, Srivastava DK, Hudson MM, Robison LL, Armstrong GT, Ness KK. Association of Exercise Intolerance With Emotional Distress, Attainment of Social Roles, and Health-Related Quality of Life Among Adult Survivors of Childhood Cancer. JAMA Oncol. e-Pub 2020. PMID: 32584369.
Friedman DN, Moskowitz CS, Hilden P, Howell RM, Weathers RE, Smith SA, Wolden SL, Tonorezos ES, Mostoufi-Moab S, Chow EJ, Meacham LR, Chou JF, Whitton JA, Leisenring WM, Robison LL, Armstrong GT, Oeffinger KC, Sklar CA. Radiation Dose and Volume to the Pancreas and Subsequent Risk of Diabetes Mellitus. J Natl Cancer Inst 112(5):525-532, 2020. e-Pub 2020. PMID: 31329225.
Gronberg MP, Tailor RC, Smith SA, Kry SF, Followill DS, Stojadinovic S, Niedzielski JS, Lindsay PE, Krishnan S, Aguirre F, Fujimoto TN, Taniguchi CM, Howell RM. A Mail Audit Independent Peer Review System for Dosimetry Verification of a Small Animal Irradiator. Radiat Res 193(4):341-350, 2020. e-Pub 2020. PMID: 32068498.
Mueller S, Kline CN, Buerki RA, Chen Y, Yasui Y, Howell R, Oeffinger KC, Leisenring WM, Robison LL, Armstrong GT, Fullerton HJ, Krull KR. Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study. Cancer 126(5):1051-1059, 2020. e-Pub 2020. PMID: 31809558.
Yeh JM, Ward ZJ, Chaudhry A, Liu Q, Yasui Y, Armstrong GT, Gibson TM, Howell R, Hudson MM, Krull KR, Leisenring WM, Oeffinger KC, Diller L. Life Expectancy of Adult Survivors of Childhood Cancer Over 3 Decades. JAMA Oncol 6(3):350-357, 2020. e-Pub 2020. PMID: 31895405.
Clark RA, Mostoufi-Moab S, Yasui Y, Vu NK, Sklar CA, Motan T, Brooke RJ, Gibson TM, Oeffinger KC, Howell RM, Smith SA, Lu Z, Robison LL, Chemaitilly W, Hudson MM, Armstrong GT, Nathan PC, Yuan Y. Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE). Lancet Oncol 21(3):436-445, 2020. e-Pub 2020. PMID: 32066539.
Kry SF, Alvarez P, Cygler JE, DeWerd LA, Howell RM, Meeks S, O'Daniel J, Reft C, Sawakuchi G, Yukihara EG, Mihailidis D. AAPM TG 191 Clinical Use of Luminescent Dosimeters: TLDs and OSLDs. Med Phys 47(2):e19-e51, 2020. e-Pub 2020. PMID: 31574174.
Schonfeld SJ, Howell RM, Smith SA, Neglia JP, Turcotte LM, Arnold MA, Inskip PD, Oeffinger KC, Moskowitz CS, Henderson TO, Leisenring WM, Gibson TM, Berrington de González A, Sampson JN, Chanock SJ, Tucker MA, Bhatia S, Robison LL, Armstrong GT, Morton LM. Comparison of Radiation Dose Reconstruction Methods to Investigate Late Adverse Effects of Radiotherapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study. Radiat Res 193(2):95-106, 2020. e-Pub 2020. PMID: 31794291.
Ness KK, Plana JC, Joshi VM, Luepker RV, Durand JB, Green DM, Partin RE, Santucci AK, Howell RM, Srivastava DK, Hudson MM, Robison LL, Armstrong GT. Exercise Intolerance, Mortality, and Organ System Impairment in Adult Survivors of Childhood Cancer. J Clin Oncol 38(1):JCO1901661, 2020. e-Pub 2020. PMID: 31622133.
Hayek S, Gibson TM, Leisenring WM, Guida JL, Gramatges MM, Lupo PJ, Howell RM, Oeffinger KC, Bhatia S, Edelstein K, Hudson MM, Robison LL, Nathan PC, Yasui Y, Krull KR, Armstrong GT, Ness KK. Prevalence and Predictors of Frailty in Childhood Cancer Survivors and Siblings: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 38(3):JCO1901226, 2020. e-Pub 2020. PMID: 31800343.
Mulrooney DA, Hyun G, Ness KK, Ehrhardt MJ, Yasui Y, Duprez D, Howell RM, Leisenring WM, Constine LS, Tonorezos E, Gibson TM, Robison LL, Oeffinger KC, Hudson MM, Armstrong GT. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort. BMJ 368:l6794, 2020. e-Pub 2020. PMID: 31941657.
Glenn MC, Peterson CB, Followill DS, Howell RM, Pollard-Larkin JM, Kry SF. Reference dataset of users' photon beam modeling parameters for the Eclipse, Pinnacle, and RayStation treatment planning systems. Med Phys 47(1):282-288, 2020. e-Pub 2020. PMID: 31667870.
Im C, Li N, Moon W, Morton LM, Leisenring WM, Howell RM, Oeffinger KC, Sklar CA, Wilson CL, Sapkota Y, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y. HAGHL genetic variants increase first fracture risk (FFR) in female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE). J Clin Oncol 38(15), 2020. e-Pub 2020.
Dixon S, Lu L, Wilson CL, Jefferies JL, Merchant TE, Howell RM, Ness KK, Kumar Srivastava D, Hudson MM, Robison LL, Chemaitilly W, Armstrong GT. Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort. J Clin Oncol 38(15), 2020. e-Pub 2020.
Weil BR, Green DM, Murphy AJ, Liu Q, Howell RM, Bertero Weldon C, Mullen EA, Madenci AL, Leisenring WM, Neglia JP, Oeffinger KC, Termuhlen AM, Mostoufi-Moab S, Levine J, Krull KR, Yasui Y, Robison LL, Armstrong GT, Jessen Chow E, Armenian S. Treatment intensity and risk of chronic health conditions and late mortality among long-term survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study. J Clin Oncol 38(15), 2020. e-Pub 2020.
Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Jessen Chow E, Oeffinger KC, Armstrong GT, Ness KK, Kadan-Lottick NS. Neuromuscular dysfunction and associated health/socioeconomic outcomes: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 38(15), 2020. e-Pub 2020.
Ghosh T, Chen Y, Dietz AC, Armstrong GT, Howell RM, Mulrooney DA, Turcotte LM, Yuan Y, Yasui Y, Neglia JP. Lung cancer as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 38(15), 2020. e-Pub 2020.
Veiga LH, Curtis RE, Morton LM, Withrow DR, Howell RM, Smith SA, Weathers RE, Oeffinger KC, Moskowitz CS, Henderson TO, Arnold MA, Gibson TM, Leisenring WM, Neglia JP, Turcotte LM, Whitton JA, Robison LL, Armstrong GT, Inskip PD, Berrington de Gonzalez A. Association of Breast Cancer Risk After Childhood Cancer With Radiation Dose to the Breast and Anthracycline Use: A Report From the Childhood Cancer Survivor Study. JAMA Pediatr 173(12):1171-1179, 2019. e-Pub 2019. PMID: 31657853.
van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab 104(12):6101-6115, 2019. e-Pub 2019. PMID: 31373627.
Turcotte LM, Liu Q, Yasui Y, Henderson TO, Gibson TM, Leisenring W, Arnold MA, Howell RM, Green DM, Armstrong GT, Robison LL, Neglia JP. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort. J Clin Oncol 37(34):JCO1900129, 2019. e-Pub 2019. PMID: 31622130.
Madenci AL, Dieffenbach BV, Liu Q, Yoneoka D, Knell J, Gibson TM, Yasui Y, Leisenring WM, Howell RM, Diller LR, Krull KR, Armstrong GT, Oeffinger KC, Murphy AJ, Weil BR, Weldon CB. Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 125(21):3873-3881, 2019. e-Pub 2019. PMID: 31322729.
Chemaitilly W, Liu Q, van Iersel L, Ness KK, Li Z, Wilson CL, Brinkman TM, Klosky JL, Barnes N, Clark KL, Howell RM, Smith SA, Krasin MJ, Metzger ML, Armstrong GT, Bishop MW, van Santen HM, Pui CH, Srivastava DK, Yasui Y, Hudson MM, Robison LL, Green DM, Sklar CA. Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study. J Clin Oncol 37(32):JCO1900738, 2019. e-Pub 2019. PMID: 31557085.
Dixon SB, Li N, Yasui Y, Bhatia S, Casillas JN, Gibson TM, Ness KK, Porter JS, Howell RM, Leisenring WM, Robison LL, Hudson MM, Krull KR, Armstrong GT. Racial and ethnic disparities in neurocognitive, emotional, and quality-of-life outcomes in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Cancer 125(20):3666-3677, 2019. e-Pub 2019. PMID: 31291014.
Dietz AC, Seidel K, Leisenring WM, Mulrooney DA, Tersak JM, Glick RD, Burnweit CA, Green DM, Diller LR, Smith SA, Howell RM, Stovall M, Armstrong GT, Oeffinger KC, Robison LL, Termuhlen AM. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol 20(10):1420-1431, 2019. e-Pub 2019. PMID: 31471158.
Kisling K, Zhang L, Shaitelman SF, Anderson D, Thebe T, Yang J, Balter PA, Howell RM, Jhingran A, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM, Court L. Automated treatment planning of postmastectomy radiotherapy. Med Phys 46(9):3767-3775, 2019. e-Pub 2019. PMID: 31077593.
Geller AC, Keske RR, Haneuse S, Davine JA, Emmons KM, Daniel CL, Gibson TM, Marghoob A, Mertens AC, McDonald AJ, Robison LL, Howell RM, Whitton JA, Coroiu A, Leisenring WM, Armstrong GT. Skin cancer early detection practices among adult survivors of childhood cancer treated with radiation. J Invest Dermatol 139(9):1898-1905.e2, 2019. e-Pub 2019. PMID: 30959042.
Sapkota Y, Turcotte LM, Ehrhardt MJ, Howell RM, Arnold MA, Wilson CL, Leisenring W, Wang Z, Sampson J, Dagnall CL, Karlins E, Li SA, Hicks BD, Weathers R, Smith SA, Shelton K, Liu Q, Tucker MA, Chanock SJ, Zhang J, Hudson MM, Neglia JP, Armstrong GT, Robison LL, Morton LM, Bhatia S, Yasui Y. Genome-Wide Association Study in irradiated Childhood Cancer Survivors identifies HTR2A for subsequent basal cell carcinoma. J Invest Dermatol 139(9):2042-2045.e8, 2019. e-Pub 2019. PMID: 30910758.
Moskowitz CS, Chou JF, Neglia JP, Partridge AH, Howell RM, Diller LR, Novetsky Friedman D, Barnea D, Morton LM, Turcotte LM, Arnold MA, Leisenring WM, Armstrong GT, Robison LL, Oeffinger KC, Henderson TO. Mortality After Breast Cancer Among Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 37(24):2120-2130, 2019. e-Pub 2019. PMID: 31260644.
Howell RM, Smith SA, Weathers RE, Kry SF, Stovall M. Adaptations to a generalized radiation dose reconstruction methodology for use in epidemiologic studies: An update from the MD Anderson Late Effect Group. Radiat Res 192(2):169-188, 2019. e-Pub 2019. PMID: 31211642.
Ehrhardt MJ, Howell CR, Hale K, Baassiri MJ, Rodriguez C, Wilson CL, Joshi SS, Lemond TC, Shope S, Howell RM, Wang Z, Srivastava D, Mulrooney DA, Zhang J, Robison LL, Ness KK, Hudson MM. Subsequent breast cancer in female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE). J Clin Oncol 37(19):1647-1656, 2019. e-Pub 2019. PMID: 31075046.
Kisling K, Johnson JL, Simonds H, Zhang L, Jhingran A, Beadle BM, Burger H, du Toit M, Joubert N, Makufa R, Shaw W, Trauernicht C, Balter P, Howell RM, Schmeler K, Court L. A risk assessment of automated treatment planning and recommendations for clinical deployment. Med Phys 46(6):2567-2574, 2019. e-Pub 2019. PMID: 31002389.
Bates JE, Howell RM, Liu Q, Yasui Y, Mulrooney DA, Dhakal S, Smith SA, Leisenring WM, Indelicato DJ, Gibson TM, Armstrong GT, Oeffinger KC, Constine LS. Therapy-related cardiac risk in childhood cancer survivors: An analysis of the childhood cancer survivor study. J Clin Oncol 37(13):1090-1101, 2019. e-Pub 2019. PMID: 30860946.
Daniel LC, Wang M, Mulrooney DA, Srivastava DK, Schwartz LA, Edelstein K, Brinkman TM, Zhou ES, Howell RM, Gibson TM, Leisenring W, Oeffinger KC, Neglia J, Robison LL, Armstrong GT, Krull KR. Sleep, emotional distress, and physical health in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Psychooncology 28(4):903-912, 2019. e-Pub 2019. PMID: 30817058.
Baltz GC, Chi PM, Wong PF, Wang C, Craft DF, Kry SF, Lin SSH, Garden AS, Smith SA, Howell RM. Development and validation of a 3D‐printed bolus cap for total scalp irradiation. J Appl Clin Med Phys 20(3):89-96, 2019. e-Pub 2019. PMID: 30821903.
Salloum R, Chen Y, Yasui Y, Packer R, Leisenring W, Wells E, King A, Howell R, Gibson TM, Krull KR, Robison LL, Oeffinger KC, Fouladi M, Armstrong GT. Late morbidity and mortality among medulloblastoma survivors diagnosed across three decades: A report from the Childhood Cancer Survivor Study. J Clin Oncol 37(9):731-740, 2019. e-Pub 2019. PMID: 30730781.
Kisling K, Zhang L, Simonds H, Fakie N, Yang J, McCarroll R, Balter P, Burger H, Bogler O, Howell R, Schmeler K, Mejia M, Beadle BM, Jhingran A, Court L. Fully automatic treatment planning for external-beam radiation therapy of locally advanced cervical cancer: A tool for low-resource clinics. J Glob Oncol 5:1-9, 2019. e-Pub 2019. PMID: 30629457.
Ger RB, Meier JG, Pahlka RB, Gay S, Mumme R, Fuller CD, Li H, Howell RM, Layman RR, Stafford RJ, Zhou S, Mawlawi O, Court LE. Effects of alterations in positron emission tomography imaging parameters on radiomics features. PLoS One 14(9):e0221877, 2019. e-Pub 2019. PMID: 31487307.
Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J, Fuller CD, Li H, Howell RM, Layman RR, Mawlawi O, Stafford RJ, Aerts H, Court LE. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients. PLoS One 14(9):e0222509, 2019. e-Pub 2019. PMID: 31536526.
Wang Z, Liu Q, Wilson CL, Easton J, Mulder H, Chang TC, Rusch MC, Edmonson MN, Rice SV, Ehrhardt MJ, Howell RM, Kesserwan CA, Wu G, Nichols KE, Downing JR, Hudson MM, Zhang J, Yasui Y, Robison LL. Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE). Clin Cancer Res 24(24):6230-6235, 2018. e-Pub 2018. PMID: 30366939.
Gibson TM, Mostoufi-Moab S, Stratton KL, Leisenring WM, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 19(12):1590-601, 2018. e-Pub 2018. PMID: 30416076.
Craft DF, Balter P, Woodward W, Kry SF, Salehpour M, Ger R, Peters M, Baltz G, Traneus E, Howell RM. Design, fabrication, and validation of patient-specific electron tissue compensators for postmastectomy radiation therapy. Physics and Imaging in Radiation Oncology 8:38-43, 2018. e-Pub 2018. PMID: 33458415.
Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE. Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph 69:134-139, 2018. e-Pub 2018. PMID: 30268005.
Glenn MC, Hernandez V, Saez J, Followill DS, Howell RM, Pollard JM, Zhou S, Kry SF. Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance. Phys Med Biol 63(20), 2018. e-Pub 2018. PMID: 30230475.
Madenci AL, Weil BR, Liu Q, Murphy AJ, Gibson TM, Yasui Y, Leisenring WM, Howell RM, Tinkle CL, Nekhlyudov L, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB. Long-term risk of venous thromboembolism in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol:JCO2018784595. e-Pub 2018. PMID: 30216123.
Schulte F, Brinkman TM, Li C, Fay-McClymont T, Srivastava DK, Ness KK, Howell RM, Mueller S, Wells E, Strother D, Lafay-Cousin L, Leisenring W, Robison LL, Armstrong GT, Krull KR. Social adjustment in adolescent survivors of pediatric central nervous system tumors: A report from the Childhood Cancer Survivor Study (CCSS). Cancer 124(17):3596-3608, 2018. e-Pub 2018. PMID: 30067866.
Brooke RJ, Im C, Wilson CL, Krasin MJ, Liu Q, Li Z, Sapkota Y, Moon W, Morton LM, Wu G, Wang Z, Chen W, Howell RM, Armstrong GT, Bhatia S, Mostoufi-Moab S, Seidel K, Chanock SJ, Zhang J, Green DM, Sklar CA, Hudson MM, Robison LL, Chemaitilly W, Yasui Y. A high-risk haplotype for premature menopause in childhood cancer survivors exposed to gonadotoxic therapy. J Natl Cancer Inst 110(8):895-904, 2018. e-Pub 2018. PMID: 29432556.
Zheng DJ, Krull KR, Chen Y, Diller L, Yasui Y, Leisenring W, Brouwers P, Howell R, Lai JS, Balsamo L, Oeffinger KC, Robison LL, Armstrong GT, Kadan-Lottick NS. Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study. Cancer 124(15):3220-3230, 2018. e-Pub 2018. PMID: 29888538.
Ger RB, Zhou S, Chi PM, Lee HJ, Layman RR, Jones AK, Goff DL, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE, Mackin DS. Comprehensive investigation on controlling for CT imaging variabilities in radiomics studies. Sci Rep 8(1):13047, 2018. e-Pub 2018. PMID: 30158540.
Kry SF, Peterson CB, Howell RM, Izewska J, Lye J, Clark CH, Nakamura M, Hurkmans C, Alvarez P, Alves A, Bokulic T, Followill D, Kazantsev P, Lowenstein J, Molineu A, Palmer J, Smith SA, Taylor P, Wesolowska P, Williams I. Remote beam output audits: a global assessment of results out of tolerance. phiRO 7:39-44, 2018. e-Pub 2018. PMID: 31872085.
Ger RB, Yang J, Ding Y, Jacobsen MC, Cardenas CE, Fuller CD, Howell RM, Li H, Stafford RJ, Zhou S, Court LE. Synthetic head and neck and phantom images for determining deformable image registration accuracy in magnetic resonance imaging. Med Phys. e-Pub 2018. PMID: 30007075.
Wang Z, Wilson CL, Easton J, Thrasher A, Mulder H, Liu Q, Hedges DJ, Wang S, Rusch MC, Edmonson MN, Levy S, Lanctot JQ, Caron E, Shelton K, Currie K, Lear M, Patel A, Rosencrance C, Shao Y, Vadodaria B, Yergeau D, Sapkota Y, Brooke RJ, Moon W, Rampersaud E, Ma X, Chang TC, Rice SV, Pepper C, Zhou X, Chen X, Chen W, Jones A, Boone B, Ehrhardt MJ, Krasin MJ, Howell RM, Phillips NS, Lewis C, Srivastava D, Pui CH, Kesserwan CA, Wu G, Nichols KE, Downing JR, Hudson MM, Yasui Y, Robison LL, Zhang J. Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J Clin Oncol 36(20):JCO2018778589, 2018. e-Pub 2018. PMID: 29847298.
Weil BR, Madenci AL, Liu Q, Howell RM, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Smith SA, Tonorezos ES, Friedman DN, Constine LS, Tinkle CL, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB. Late infection-related mortality in asplenic survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 36(16):1571-1578, 2018. e-Pub 2018. PMID: 29664715.
Cheung YT, Brinkman TM, Li C, Mzayek Y, Srivastava D, Ness KK, Patel SK, Howell RM, Oeffinger KC, Robison LL, Armstrong GT, Krull KR. Chronic health conditions and neurocognitive function in aging survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Natl Cancer Inst 110(4):411-419, 2018. e-Pub 2018. PMID: 29088360.
Craft DF, Kry SF, Balter P, Salehpour M, Woodward W, Howell RM. Material matters: Analysis of density uncertainty in 3D printing and its consequences for radiation oncology. Med Phys 45(4):1614-1621, 2018. e-Pub 2018. PMID: 29493803.
Taddei PJ, Khater N, Youssef B, Howell RM, Jalbout W, Zhang R, Geara FB, Giebeler A, Mahajan A, Mirkovic D, Newhauser WD. Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers. Biomed. Phys. Eng 4(2), 2018. e-Pub 2018.
Langballe R, John EM, Malone KE, Bernstein L, Knight JA, Lynch CF, Howell RM, Shore R, Woods M, Concannon P, Collaborative Group WS, Bernstein JL, Mellemkjær L. Agreement between self-reported and register-based cardiovascular events among danish breast cancer survivors. J Cancer Surviv 12(1):95-100, 2018. e-Pub 2018. PMID: 28963606.
Taddei PJ, Khater N, Youssef B, Howell RM, Jalbout W, Zhang R, Geara FB, Giebeler A, Mahajan A, Mirkovic D, Newhauser WD. Low- and middle-income countries can reduce risks of subsequent neoplasms by referring pediatric craniospinal cases to centralized proton treatment centers. Biomed Phys Eng Express 4(2), 2018. e-Pub 2018. PMID: 30038799.
Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, Whitton JA, Burdette L, Chung C, Hicks BD, Jones K, Machiela MJ, Vogt A, Wang Z, Yeager M, Neale G, Lear M, Strong LC, Yasui Y, Stovall M, Weathers RE, Smith SA, Howell R, Davies SM, Radloff GA, Onel K, de González AB, Inskip PD, Rajaraman P, Fraumeni JF, Bhatia S, Chanock SJ, Tucker MA, Robison LL. Genome-wide association study to identify susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer. J Natl Cancer Inst 109(11), 2017. e-Pub 2017. PMID: 29059430.
Ger RB, Yang J, Ding Y, Jacobsen MC, Fuller CD, Howell RM, Li H, Jason Stafford R, Zhou S, Court LE. Accuracy of deformable image registration on magnetic resonance images in digital and physical phantoms. Med Phys 44(10):5153, 2017. e-Pub 2017. PMID: 28622410.
Kry SF, Bednarz B, Howell RM, Dauer L, Followill D, Klein E, Paganetti H, Wang B, Wuu CS, Xu XG. AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys 44(10):e391-e429, 2017. e-Pub 2017. PMID: 28688159.
Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A multi-institutional comparison of dynamic contrast-enhanced magnetic resonance imaging parameter calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
Craft DF, Howell RM. Preparation and fabrication of a full-scale, sagittal-sliced, 3D-printed, patient-specific radiotherapy phantom. J Appl Clin Med Phys 18(5):285-292, 2017. e-Pub 2017. PMID: 28857407.
Kerns JR, Stingo F, Followill DS, Howell RM, Melancon A, Kry SF. Treatment planning system calculation errors are present in most imaging and radiation oncology core-Houston phantom failures. Int J Radiat Oncol Biol Phys 98(5):1197-1203, 2017. e-Pub 2017. PMID: 28721904.
Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, Oeffinger KC. Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study (CCSS). Br J Cancer 117(2):290-299, 2017. e-Pub 2017. PMID: 28632729.
Shaitelman SF, Howell RM, Smith BD. Effects of smoking on late toxicity from breast radiation. J Clin Oncol 35(15):JCO2017722660, 2017. e-Pub 2017. PMID: 28319432.
Turcotte LM, Liu Q, Yasui Y, Arnold MA, Hammond S, Howell RM, Smith SA, Weathers RE, Henderson TO, Gibson TM, Leisenring W, Armstrong GT, Robison LL, Neglia JP. Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015. JAMA 317(8):814-824, 2017. e-Pub 2017. PMID: 28245323.
Huang JY, Followill DS, Howell RM, Liu X, Mirkovic D, Stingo FC, Kry SF. Approaches to reducing photon dose calculation errors near metal implants. Med Phys 43(9):5117, 2016. e-Pub 2016. PMID: 27587042.
Burmeister J, Chen Z, Chetty IJ, Dieterich S, Doemer A, Dominello MM, Howell RM, McDermott P, Nalichowski A, Prisciandaro J, Ritter T, Smith C, Schreiber E, Shafman T, Sutlief S, Xiao Y. The american society for radiation oncology's 2015 core physics curriculum for radiation oncology residents. Int J Radiat Oncol Biol Phys 95(4):1298-303, 2016. e-Pub 2016. PMID: 27354135.
Eley JG, Friedrich T, Homann KL, Howell RM, Scholz M, Durante M, Newhauser WD. Comparative risk predictions of second cancers after carbon-ion therapy versus proton therapy. Int J Radiat Oncol Biol Phys 95(1):279-86, 2016. e-Pub 2016. PMID: 27084647.
Howell RM, Burgett EA, Isaacs D, Price Hedrick SG, Reilly MP, Rankine LJ, Grantham KK, Perkins S, Klein EE. Measured neutron spectra and dose equivalents from a mevion single-room, passively scattered proton system used for craniospinal irradiation. Int J Radiat Oncol Biol Phys 95(1):249-57, 2016. e-Pub 2016. PMID: 27084645.
Cardenas CE, Nitsch PL, Kudchadker RJ, Howell RM, Kry SF. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. J Appl Clin Med Phys 17(4):6216, 2016. e-Pub 2016. PMID: 27455499.
Yusuf SW, Howell RM, Gomez D, Pinnix CC, Iliescu CA, Banchs J. Radiation-related heart and vascular disease. Future Oncol 11(14):2067-76, 2015. e-Pub 2015. PMID: 26198837.
Rechner LA, Eley JG, Howell RM, Zhang R, Mirkovic D, Newhauser WD. Risk-optimized proton therapy to minimize radiogenic second cancers. Phys Med Biol 60(10):3999-4013, 2015. e-Pub 2015. PMID: 25919133.
Huang JY, Kerns JR, Nute JL, Liu X, Balter PA, Stingo FC, Followill DS, Mirkovic D, Howell RM, Kry SF. An evaluation of three commercially available metal artifact reduction methods for CT imaging. Phys Med Biol 60(3):1047-67, 2015. e-Pub 2015. PMID: 25585685.
Eley J, Newhauser W, Homann K, Howell R, Schneider C, Durante M, Bert C. Implementation of an analytical model for leakage neutron equivalent dose in a proton radiotherapy planning system. Cancers (Basel) 7(1):427-38, 2015. e-Pub 2015. PMID: 25768061.
Zhang R, Howell RM, Taddei PJ, Giebeler A, Mahajan A, Newhauser WD. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. Radiother Oncol 113(1):84-8, 2014. e-Pub 2014. PMID: 25128084.
Howell RM, Burgett EA. Secondary neutron spectrum from 250-MeV passively scattered proton therapy: measurement with an extended-range bonner sphere system. Med Phys 41(9):092104, 2014. e-Pub 2014. PMID: 25186404.
Pulliam KB, Huang JY, Howell RM, Followill D, Bosca R, O'Daniel J, Kry SF. Comparison of 2D and 3D gamma analyses. Med Phys 41(2):021710, 2014. e-Pub 2014. PMID: 24506601.
Huang JY, Klund DE, Childress NL, Howell RM, Mirkovic D, Followill DS, Kry SF. Investigation of various energy deposition kernel refinements for the convolution/superposition method. Med Phys 40, 121721(12), 2013. e-Pub 2013. PMID: 24320507.
Taddei PJ, Jalbout W, Howell RM, Khater N, Geara F, Homann K, Newhauser WD. Analytical model for out-of-field dose in photon craniospinal irradiation. Phys Med Biol 58(21):7463-79, 2013. e-Pub 2013. PMID: 24099782.
Casey KE, Alvarez P, Kry SF, Howell RM, Lawyer A, Followill D. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry. Med Phys 40, 112102(11):112102, 2013. e-Pub 2013. PMID: 24320455.
Wang X, Zhang X, Li X, Amos RA, Shaitelman SF, Hoffman K, Howell R, Salehpour M, Zhang SX, Sun TL, Smith B, Tereffe W, Perkins GH, Buchholz TA, Strom EA, Woodward WA. Accelerated partial-breast irradiation using intensity-modulated proton radiotherapy: Do uncertainties outweigh potential benefits?. Br J Radiol 86(1029):20130176, 2013. e-Pub 2013. PMID: 23728947.
Zhang R, Howell R, Homann K, Giebeler A, Taddei P, Mahajan A, Newhauser W. Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol 8(1):184, 2013. e-Pub 2013.
Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, Curtis RE, Aleman BM, Travis L, Kwon D, Morton LM. Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients. Int J Radiat Oncol Biol Phys 86(4):694-701, 2013. e-Pub 2013. PMID: 23628135.
Han T, Followill D, Mikell J, Repchak R, Molineu A, Howell R, Salehpour M, Mourtada F. Dosimetric impact of Acuros XB deterministic radiation transport algorithm for heterogeneous dose calculation in lung cancer. Med Phys 40(5):051710, 2013. e-Pub 2013. PMID: 23635258.
Pérez-Andújar A, Newhauser WD, Taddei PJ, Mahajan A, Howell RM. The predicted relative risk of premature ovarian failure for three radiotherapy modalities in a girl receiving craniospinal irradiation. Phys Med Biol 58(10):3107-23, 2013. e-Pub 2013. PMID: 23603657.
Giebeler A, Newhauser WD, Amos RA, Mahajan A, Homann K, Howell RM. Standardized treatment planning methodology for passively scattered proton craniospinal irradiation. Radiat Oncol 8:32, 2013. e-Pub 2013. PMID: 23375151.
Zhang R, Howell RM, Giebeler A, Taddei PJ, Mahajan A, Newhauser WD. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Phys Med Biol 58(4):807-823. e-Pub 2013. PMID: 23322160.
Rechner LA, Howell RM, Zhang R, Newhauser WD. Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer. Phys Med Biol 57(23):N469-79, 2012. e-Pub 2012. PMID: 23154795.
Rechner LA, Howell RM, Zhang R, Etzel C, Lee AK, Newhauser WD. Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol 57(21):7117-32, 2012. e-Pub 2012. PMID: 23051714.
Han T, Mourtada F, Kisling K, Mikell J, Followill D, Howell R. Experimental validation of deterministic Acuros XB algorithm for IMRT and VMAT dose calculations with the Radiological Physics Center's head and neck phantom. Med Phys 39(4):2193-202, 2012. e-Pub 2012. PMID: 22482641.
Howell RM, Giebeler A, Koontz-Raisig W, Mahajan A, Etzel CJ, D'Amelio AM, Homann KL, Newhauser WD. Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma. Radiat Oncol 7:116, 2012. e-Pub 2012. PMID: 22828073.
Pulliam KB, Howell RM, Followill D, Luo D, White RA, Kry SF. The clinical impact of the couch top and rails on IMRT and arc therapy. Phys Med Biol 56(23):7435-47, 2011. e-Pub 2011. PMID: 22056949.
Scarboro SB, Followill DS, Howell RM, Kry SF. Variations in photon energy spectra of a 6 MV beam and their impact on TLD response. Med Phys 38(5):2619-2628, 2011. e-Pub 2011. PMID: 21776799.
Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 38(1):34-9, 2011. e-Pub 2011. PMID: 21361172.
Howell RM, Burgett EA, Wiegel B, Hertel NE. Calibration of a bonner sphere extension (BSE) for high-energy neutron spectrometry. Radiat Meas 45(10):1233-1237, 2010. e-Pub 2010. PMID: 22888283.
Wang Z, Howell RM, Burgett EA, Kry SF, Hertel NE, Salehpour M. Calibration of indium response functions in an Au-In-BSE system up to 800MeV. Radiat Prot Dosimetry 139(4):doi:10.1093/rpd/ncp282, 2010. e-Pub 2010. PMID: 20008907.
Scarboro SB, Stovall M, White A, Smith SA, Yaldo D, Kry SF, Howell RM. Effect of organ size and position on out-of-field dose distributions during radiation therapy. Phys Med Biol 55(23):7025-36, 2010. e-Pub 2010. PMID: 21076195.
Taddei PJ, Howell RM, Krishnan S, Scarboro SB, Mirkovic D, Newhauser WD. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma. Phys Med Biol 55(23):7055-65, 2010. e-Pub 2010. PMID: 21076199.
Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol 55(23):6999-7008, 2010. e-Pub 2010. PMID: 21076191.
Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol 55(23):7009-23, 2010. e-Pub 2010. PMID: 21076193.
Howell RM, Kry SF, Burgett E, Hertel NE, Followill DS. Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. Med Phys 36(9):4027-38, 2009. e-Pub 2009. PMID: 19810475.
Kry SF, Howell RM, Salehpour M, Followill DS. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy. Med Phys 36(4):1244-50, 2009. e-Pub 2009. PMID: 19472632.
Kry SF, Howell RM, Polf J, Mohan R, Vassiliev ON. Treatment vault shielding for a flattening filter-free medical linear accelerator. Phys Med Biol 54(5):1265-73, 2009. e-Pub 2009. PMID: 19190359.
Burgett EA, Hertel NE, Howell RM. Energy response and angular dependence of a bonner sphere. IEEE TNS 56(3):1325-1329, 2009. e-Pub 2009.
Scarboro SA, Hertel NE, Burgett EA, Howell RM. Use of a thyroid probe for assaying internal contamination following a radioactive dispersal device (RDD). Nucl Technol 168(1):169-172, 2009. e-Pub 2009.
Howell RM, Kry SF, Burgett E, Followill D, Hertel NE. Effects of tertiary MLC configuration on secondary neutron spectra from 18-MV x-ray beams for the Varian 21EX linear accelerator. Med Phys 36(9):4039-4046, 2009. e-Pub 2009. PMID: 19810476.
Howell RM, Burgett EA, Hertell NE, Kry SF, Wang Z, Salehpour M. Measurement of high-energy neutron spectra with a bonner sphere extension. Nucl Technol 168(2):333-339, 2009. e-Pub 2009.
Wang Z, Kry SF, Howell RM, Salehpour M. Comparison of unfolding methods for the determination of neutron spectrum and ambient dose equivalent. Nucl Technol 168(3):610-614, 2009. e-Pub 2009.
Wang Z, Howell RM, Kry SF, Burgett EA, Hertel NE, Salehpour M. Characterization of a gold-and-indium dual-activation-foil-based bonner sphere system. Nucl Technol 168(3):603-609, 2009. e-Pub 2009.
Wang Z, Hutchinson JD, Hertel NE, Burgett E, Howell RM. Study of a gold-foil-based multisphere neutron spectrometer. Radiat Prot Dosimetry 128(3):289-93, 2008. e-Pub 2008. PMID: 17681965.
Wang Z, Hutchinson JD, Hertel NE, Burgett E, Howell RM. Study of a gold-foil based multi-sphere neutron spectrometer. Radiat Prot Dosimetry 128(3):289-293, 2008. e-Pub 2008.
Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free clinac. Med Phys 35(5):1906-11, 2008. e-Pub 2008. PMID: 18561666.
Howell RM, Smith IP, Jarrio C. Establishing action levels for EPID-based QA for IMRT. J Appl Clin Med Phys 9(3):16-25, 2008. e-Pub 2008. PMID: 18716584.
Howell RM, Hertel NE, Wang Z, Hutchinson J, Fullerton GD. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies. Med Phys 33(2):360-8, 2006. e-Pub 2006. PMID: 16532941.
Howell RM, Hertel NE, Wang Z, Hutchinson J. RBE or effective dose to evaluate the effect of different beam energies for intensity modulated radiation therapy. Nucl Instrum Meth 562(2):1024-28, 2006. e-Pub 2006.
Koshy M, Paulino AC, Howell RM, Schuster D, Davis LW. Comparison of CT and FDG-pet-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncl Biol Phys 61(5):1385-92, 2005. e-Pub 2005.
Howell RM, Ferenci MS, Hertel NE, Fullerton GD. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery. Med Phys 32(3):786-93, 2005. e-Pub 2005. PMID: 15839351.
Howell RM, Ferenci MS, Hertel NE, Fullerton GD, Fox T, Davis LW. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT. Radiat Prot Dosimetry 115(1-4):508-12, 2005. e-Pub 2005. PMID: 16381776.
Koshy K, Landry JC, Lawson JD, Staley A Esiashivili N, Howell RM, Ghavidel S, Davis LW. Intensity modulated radiation therapy (IMRT) for retroperitoneal sarcoma-a case for dose escalation and organ at risk (OAR) toxicity reduction. Sarcoma 7(3):137-48, 2003. e-Pub 2003.

Invited Articles

Howell RM. Book review: National council on radiation protection and measurements (NCRP) report No. 170, second primary cancers and cardiovascular disease after radiation therapy. Med Phys 39(12):7729-7731, 2012. e-Pub 2012.

Review Articles

Bates, JE, Marples, B, Hudson, MM, Williams, A, Marcus, KJ, Howell, RM, Paulino, AC, Constine, LS. Biodevelopmental Considerations in Pediatric Patients With Cancer and Childhood Cancer Survivors. International Journal of Radiation Oncology Biology Physics 119(2):354-359, 2024. e-Pub 2024. PMID: 37966404.
Hall MD, Howell RM, Jackson A, Owens CA, Hernandez S, Castellino SM, Ronckers CM, Constine LS, Bradley JA. Liver Late Effects in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 119(2):575-587, 2024. e-Pub 2023. PMID: 37480885.
Pollard-Larkin JM, Briere TM, Kudchadker RJ, Sadagopan R, Nitsch PL, Wang XA, Salehpour M, Wang J, Vedam S, Nelson CL, Sahoo N, Zhu XR, Court LE, Balter PA, Robinson IJ, Yang J, Howell RM, Followill DS, Kry S, Beddar SA, Martel MK. Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic. Adv Radiat Oncol 6(4):100683, 2021. e-Pub 2021. PMID: 33824935.
Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiother Oncol 159:106-111, 2021. e-Pub 2021. PMID: 33741471.

Professional Educational Materials

Howell RM. American Association of Physicists in Medicine on-line learning center quiz, late effects from radiation therapy, secondary cancers and cardiac toxicity, quiz ID 1981, 2011.
Howell RM. American Association of Physicists in Medicine on-line learning center quiz, investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery, quiz ID 1746, 2005.

Editorials

Constine, LS, Marks, LB, Milano, MT, Ronckers, CM, Jackson, A, Hudson, MM, Marcus, KJ, Hodgson, DC, Hua, CH, Howell, RM, Marples, B, Yorke, E, Olch, AJ, Bentzen, SM. A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC). International Journal of Radiation Oncology Biology Physics 119(2):321-337, 2024. PMID: 37999712.
Howell RM. Breast diseases a yearbook quarterly 23:3, 278-280. Commentary on: Langballe R, et al., “Cardiac dose estimates from danish and swedish breast cancer radiotherapy during 1977–2001”. Radiother Oncol 100:176-183, 2011, 2012.
Howell RM, Kry SF. Breast diseases a yearbook quarterly 22:4,359-360, 2011. Commentary on: Langballe R, et al., “Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy”. Eur J Cancer 47:946-952, 2011.
Howell RM, Kry SF, Stovall MA. Breast diseases a yearbook quarterly 21:3, 367-368. 2010. Commentary on: Inskip et al., radiation dose and breast cancer risk in the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 27:3901-3907, 2009.
Kry SF, Howell RM. Breast diseases a yearbook quarterly 21:1,69-70. 2010. Commentary on: Mery et al., “Second sarcomas after radiotherapy for breast cancer: sustained risk and poor survival". Cancer 115:4055-4063, 2009.
Howell RM, Kry SF, Stovall MA. Breast diseases a yearbook quarterly 20:4,367-368, 2010. Commentary on: Yadav et al., “Nonbreast second malignancies after treatment of primary breast cancer". Int J Radiat Oncl Biol Phys 73:1489-1492, 2009.

Abstracts

Sadeghi S, Netherson TJ, Bates JE, Hill-Kayser C, Dong L, Ermoian R, Koufigar S, Lucas JT, Merchant TE, Armstrong GT, Howell RM. Evaluating Commercial Auto-Segmentation Software: Is Performance on Pediatric Organs-at-Risk Accurate?. Medical Physics 52(10):SU-330-GPD-T-571, 2025. e-Pub 2025.
Sadeghi S, Netherton TJ, Paulino AC, Chung CV, Khan MS, Owens CA, Meyers T, Bates JE, Hill-Kayser C, Dong L, Ermoian R, Koufigar S, Fu J, Lucas JT, Merchant TE, Armstrong GT, Howell RM. Do We Need Pediatric-Specific Models for Radiotherapy Auto-Contouring? a Comparative Study of Pediatric and Adult-Trained Tools. Medical Physics 52(10):SU-330-GPD-T-286, 2025. e-Pub 2025.
Brooks F, Lehmann J, Hussein M, Lye J, Nelson CL, Nakamura M, Diez P, Patel R, Greer PB, Hirashima H, Pollard-Larkin JM, Howell RM, Peterson C, Clark CH, Fry SF. Quantification of Global Dosimetry Audit Performance: Assessing the Sensitivity and Specificity of Dosimetry Audits to Esta blish Reciprocity AmongDifferent International Clinical Trials Credentialing Organizations. Medical Physics 52(10):SU-330-GPD-T-481, 2025. e-Pub 2025.
Meyers T, Owens CA, O'Connor C, Jones TS, Smith SA, Gupta AC, Hancock D, Brock KK, Court LE, Paulino AC, Pinnix CC, Moskowitz C, Ehrhardt M, Friedman D, Im C, Lee C, Leisenring W, Morton L, Neglia J, Nolan V, Oeffinger KC, Roberti S, Ronckers C, Srivastava K, Turcotte L, Armstrong GT, Bates JE, Howell RM. Development and Validation of a Principal Component Analysis Statistical Shape Pediatric/Adolescent Breast Model for Pre -CT Era Breast DoseReconstruction in Late Effect Studies of Female Childhood Cancer Survivors. Medical Physics 52(10):MO-330-BRP-12, 2025. e-Pub 2025.
Sadeghi S, Netherton T, Paulino AC, Chung C, Khan M, Bates JE, Hill-Kayser CE, Dong L, Ermoian RP, Koufigar S, Fu J, Lucas JT, Merchant TE, Armstrong GT, Howell RM. Toward Advancement of Pediatric Cancer Treatment: A Comparative Study of Pediatric-Specific Models and Adult-Trained Commercial Tools for Radiotherapy Auto-Contouring. International Journal of Radiation Oncology, Biology, Physics 123(1, Supplement):S164, 2025. e-Pub 2025.
Williams AL, Small B, Wang M, Mandelblatt JS, Ness KK, Cohen HJ, Hudson MM, Brinkman TM, Howell RM, Chow EJ, Yasui Y, Srivastava DK, Armstrong GT, Krull KR. Accelerated aging among long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology 43(16, Supplement), 2025. e-Pub 2025.
Mulrooney DA, Liu Q, Bagherzadeh-Khiabani F, Bates JE, Armstrong GT, Constine LS, Ness KK, Hudson MM, Yasui Y, Howell RM. Predicting valvular heart disease in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort (SJLIFE). Journal of Clinical Oncology 43(16, Supplement), 2025. e-Pub 2025.
Gupta AC, Taie AI, Vazquez I, Castelo A, Flint DB, Tang TT, Prasad AS, Zha Y, Robles S, O'Connor C, Leone AO, Court LE, Yang M, Yedururi S, Wu J, Long JP, Howell RM, Koay EJ, Brock KK. Development of Prediction Model for Right and Left Liver Hypertrophy to Estimate Response in Patients' Treatments Simulated with Photon Based 3DCRT and IMRT Plans. International Journal of Radiation Oncology, Biology, Physics 120(2, Supplement):217-218, 2024. e-Pub 2024.
Sadeghi S, Paulino AC, Howell RM. From Adults to Pediatrics: The Reliability and Reproducibility of AI Auto-Contouring in Pediatric Cancer Treatment. International Journal of Radiation Oncology, Biology, and Physics 120(2):e183, 2024. e-Pub 2024.
Shrestha S, Bates JE, Liu Q, Smith SA, Pinnix CC, Paulino AC, Leisenring W, Robison LL, Oeffinger KC, Constine LS, Armstrong GT, Yasui Y, Mulrooney DA, Howell RM. Quantifying Potential Risk Misclassification: Assessing the Importance of Mean Cardiac Substructure Dose in Treatment Planning andCardiac Risk Analyses across Treatment Eras. Medical Physics 51(9):6600, 2024. e-Pub 2024.
Gronberg M, Beadle BM, Fuller CD, Gay S, Netherton TJ, Wood J, Cardenas CE, Peterson C, Lim TY, Howell RM, Jhingran A, Court LE. Three-Dimensional Dose Prediction for Radiotherapy Plan Review in a Clinical Trial Setting: A Retrospective Analysis of RTOG 1016. Medical Physics 51(9):6830, 2024. e-Pub 2024.
Mehrens HS, Peterson C, Jaffray DA, Court LE, Howell RM, Pollard-Larkin JM, Kry SF. Modeling Dose Delivery Accuracy in a Head and Neck Phantom with Treatment Parameters and Machine Learning for a Multi-Institutional Study. Medical Physics 51(9):6572, 2024. e-Pub 2024.
Carrasco Rojas D, Owens CA, Gupta AC, Shrestha S, Lee C, Howell RM. Evaluation of Age-Scalable Pediatric Computational Brain for Dose Reconstruction in Historical Radiotherapy Cases. Medical Physics 51(9):6736, 2024. e-Pub 2024.
Sadeghi S, Gupta AC, Shrestha S, Owens CA, Smith SA, Howell RM. Preliminary Results of an Automated Whole-Body Dosimetry Methodology for Future Late Effects Studies of Survivors of Childhood CancerTreated in the Contemporary-Era of Radiotherapy (2000-2019). Medical Physics 51(9):6717, 2024. e-Pub 2024.
Duan L, Owens CA, Chen X, Yang J, Bates JE, Paulino AC, Pinnix CC, Mulrooney DA, Yasui Y, Howell RM. eometric and Dosimetric Evaluation of Automatic Segmentation Models for Cardiac Substructures in Pediatric Patients. Medical Physics 51(9):6614, 2024. e-Pub 2024.
Cooney T, Chen Y, Yuan Y, Galvin RT, Leisenring WM, Smith SA, Howell RM, Arnold MA, Conces M, Bowers DC, Yasui Y, Diller L, Armstrong GT, Neglia JP, Turcotte LM. Subsequent meningiomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology 41(16, Supplement), 2023. e-Pub 2023.
Bhandari R, Chen Y, Chow EJ, Howell RM, Kenney LB, Krull KR, Leisenring WM, Nathan PC, Neglia JP, Ness KK, Oeffinger KC, Snyder CF, Turcotte LM, Wong FL, Yasui Y, Armstrong GT, Armenian S. Mortality and the burden of subsequent malignant neoplasms in survivors of childhood cancer beyond age 50: A report from the Childhood Cancer Survivor Study (CCSS). https://doi.org/10.1200/JCO.2023.41.16_suppl.1005 41(16, Supplement), 2023. e-Pub 2023.
Scott H, Alvarez P, Sun R, Howell RM, Riegel A, Kry S. Extending the Lifetime of Optically Stimulated Luminescent Dosimeters for Use in Output Checks at IROC- Houston. Medical Physics 49(6):PO-GePV-T-337, 2022. e-Pub 2022.
Brooks F, Glenn M, Pollard-Larkin J, Howell RM, Peterson C, Nelson C, Clark C, Kry S. Clinical Plan Sensitivity to TPS Parameters and the Complexity Metrics That Best Capture This Relationship. Medical Physics 49(6):PO-GePV-T-312, 2022. e-Pub 2022.
Mille M, Veiga L, Curtis R, Smith S, Howell RM, Lee C, Berrington De Gonzalez A. Evaluation of Radiotherapy Treatment Characteristics for Patients in the Kaiser Permanente Breast Cancer Survivors Study. Medical Physics 49(6):PO-GePV-T-113, 2022. e-Pub 2022.
Veltchev I, Lin T, Chen X, Price R, Howell RM, Ma C. Evaluation of the Dosimetric Quality of MRI-Only HDR Brachytherapy Planning with Titanium Ring-And-Tandem Applicators. Medical Physics 49(6):PO-GePV-T-34, 2022. e-Pub 2022.
Simiele SJ, Hancock D, Ludmir EB, Smith SA, Lee C, Howell RM. A Hybrid Approach to Improve the Accuracy and Clinical Utility of Physical Anthropomorphic Phantoms 49(6):PO-GePV-M-276, 2022. e-Pub 2022.
Gronberg M, Gay S, Beadle B, Garden A, Skinner H, Netherton T, Cao W, Vazquez I, Olanrewaju A, Chung C, Cardenas C, Fuller C, Peterson C, Jhingran A, Howell RM, Lim T, Yang M, Mumme R, Court LE. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiotherapy Plans:. Medical Physics 49(6):WE-G-BRC-03, 2022. e-Pub 2022.
Kovalchuk N, Simiele E, Skinner L, Yang Y, Howell RM, Lewis J, Hui C, Blomain E, Hoppe R, Hiniker S. Stanford VMAT TBI Technique. Medical Physics 49(6):WE-C1030-IePD-F4-03, 2022. e-Pub 2022.
Edward S, Peterson C, Howell RM, Pollard-Larkin J, Kry S. Using Phantom Results to Quantify Treatment Error Among the Radiation Oncology Community 49(6):TU-H-BRA-05, 2022. e-Pub 2022.
Hernandez S, Parkes J, Burger H, Nguyen C, Rhee D, Paulino A, Netherton T, Mumme R, Guma-de La Vega J, Duryea J, Cardenas C, Howell RM, Fuentes D, Pollard-Larkin J, Court LE. Medical Physics 49(6):MO-H345-IePD-F7-01, 2022. e-Pub 2022.
Owens CA, Rigaud B, Ludmir E, Gupta A, Shrestha S, Paulino AC, Smith SA, Peterson CB, Kry SF, Lee C, Henderson T, Armstrong GT, Brock KK, Howell RM. Development and Validation of a Population-Based Anatomical Colorectal Model for Radiation Dosimetry in Late Effects Studies of Childhood CancerSurvivors. Medical Physics 40(6):MO-FG-BRB-05, 2022. e-Pub 2022.
Hartzell S, Guan F, Peterson C, Howell RM, Kry S. Sensitivity of Carbon RBE Models to Reference Parameter Variations. Medical Physics 49(6):SU-J-206-06, 2022. e-Pub 2022.
Brooks F, Glenn M, Peterson C, Nelson C, Clark C, Pollard-Larkin J, Howell RM, Kry S. How Well Does the IROC H&N Phantom Serve as a Surrogate for Different Anatomical Sites 49(6):SU-F-BRA-04, 2022. e-Pub 2022.
Webster RT, Liu W, McGrady ME, Alberts NM, Brinkman TM, Ness KK, Fuemmeler B, Kunin-Batson A, Srivastava D, Huang IC, Armstrong GT, Howell RM, Green DM, Yasui Y, Krull KR. Symptom profiles and health care utilization in long-term survivors of Survivors of Childhood Childhood Cancer Survivor (CCSS) study 40(16 Suppl), 2022. e-Pub 2022.
Gibson TM, Karyadi DM, Kapoor V, Arnold M, Berrington de Gonzalez A, Bhatia S, Conces M, Hartley S, Howell RM, Leisenring WM, Neglia JP, Turcotte LM, Yasui Y, Chanock SJ, Armstrong GT, Morton LM. Joint effects of general population polygenic risk scores (PRS) and radiation treatment on subsequent neoplasm risk among childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS) 40(16 Suppl), 2022. e-Pub 2022.
Bryce YC, Armstrong GT, Leisenring WM, Whitton J, Chow EJ, Weil R, Dieffenbach B, Howell RM, Oeffinger KC, Nathan PC, Tonorezos ES. Use and correlates of carotid ultrasound in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study 40(16 Suppl), 2022. e-Pub 2022.
De Blank P, Lange KR, Xing M, Salehabadi SM, Svivastava D, Brinkman TM, Ness KK, Oeffinger KC, Neglia JP, Krull KR, Yasui Y, Nathan PC, Howell RM, Turcotte LM, Leisenring WM, Armstrong GT, Okcu M, Bowers DC. Late mortality and morbidity among adult survivors of childhood glioma treated over three decades: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 2022. e-Pub 2022.
Dixon SB, Liu Q, Ehrhardt MJ, Chow EJ, Oeffinger KC, Mertens AC, Nathan PC, Howell RM, Leisenring WM, Krull KR, Ness KK, Hudson MM, Robison LL, Yasui Y, Armstrong GT. Modifiable risk factors for late mortality among five-year survivors of childhood cancer: A report from the Childhood Cancer Survivor Study 40(16 Suppl), 2022. e-Pub 2022.
Netherton T, Nguyen C, Cardenas C, Chung C, Klopp A, Colbert L, Rhee DJ, Peterson C, Howell R, Aggarwal A, Simonds H, Court L. A new machine learning-based clinical tool for vertebral level verification and treatment planning 170(Suppl):S1450, 2022. e-Pub 2022.
Edward S, Howell R, Balter P, Peterson C, Pollard-Larkin J, Kry S. Assessing the extent of treatment delivery errors among IROC H&N and lung phantoms 170(Suppl):S650-S651, 2022. e-Pub 2022.
Edward S, Peterson C, Howell R, Balter P, Pollard-Larkin J, Kry S. Sources of errors in radiotherapy as assessed with the IROC lung, H&N and Spine phantoms 170(Suppl):S252-S253, 2022. e-Pub 2022.
Brooks F, Glenn M, Pollard-Larkin J, Howell R, Peterson C, Nelson CL, Clark CH, Kry SF. Clinical plan sensitivity to TPS parameters & complexity metrics that best capture this relationship 170(Suppl):S726-S728, 2022. e-Pub 2022.
Owens C, Rigaud B, Ludmir E, Gupta A, Shrestha S, de la Cruz Paulino S, Peterson C, Kry S, Smith S, Brock K, Henderson T, Howell R. Development and validation of a population-based colorectal model for radiation therapy dosimetry 170(Suppl):S830-S832, 2022. e-Pub 2022.
Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, Oeffinger KC, Moskowitz CS, Henderson TO, Mertens A, Nathan PC, Yasui Y, Landier W, Armstrong GT, Robison LL, Bhatia S. Efficacy of clinical breast examination in chest-irradiated female survivors of childhood Hodgkin lymphoma (HL). J Clin Oncol 39(15), 2021. e-Pub 2021.
Novetsky Friedman D, Goodman PJ, Leisenring WM, Diller L, Lerner Cohn S, Tonorezos ES, Howell RM, Smith SA, Wolden SL, Neglia JP, Ness KK, Gibson TM, Nathan PC, Robison LL, Oeffinger KC, Armstrong GT, Sklar CA, Henderson TO. Late morbidity and mortality among survivors of neuroblastoma treated with contemporary therapy: A report from the Childhood Cancer Survivor Study. J Clin Oncol 39(15), 2021. e-Pub 2021.
Dixon SB, Liu Q, Ehrhardt MJ, Jessen Chow E, Oeffinger KC, Mertens AC, Nathan PC, Howell RM, Leisenring WM, Krull KR, Ness KK, Hudson MM, Robison LL, Yasui Y, Armstrong GT. Mortality among five-year survivors of childhood cancer: Results over five decades of follow-up in the Childhood Cancer Survivor Study. J Clin Oncol 39(15), 2021. e-Pub 2021.
Bottinor W, Im C, Armenian S, Hong B, Howell RM, Ness KK, Oeffinger KC, Armstrong GT, Yasui Y, Jessen Chow E. Overall and cardiac-specific mortality following serious cardiovascular events in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 39(15), 2021. e-Pub 2021.
Richard MA, Mostoufi-Moab S, Rathore N, Brown AL, Chanock SJ, Novetsky Friedman D, Gramatges MM, Howell RM, Kamdar K, Leisenring WM, Meacham LR, Morton LM, Oeffinger KC, Robison LL, Sapkota Y, Sklar CA, Yasui Y, Armstrong GT, Bhatia S, Lupo P. Genetic and treatment risks for diabetes mellitus (DM) in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime (SJLIFE) cohorts. J Clin Oncol 39(15), 2021. e-Pub 2021.
Wu NL, Chen Y, Dieffenbach BV, Li N, Ehrhardt MJ, Green DM, Hingorani S, Howell RM, Jefferies JL, Mulrooney DA, Oeffinger KC, Robison LL, Weil BR, Yuan Y, Yasui Y, Hudson MM, Leisenring WM, Armstrong GT, Jessen Chow E. Development and validation of a prediction model for kidney failure in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 39(15), 2021. e-Pub 2021.
Bates JE, Shrestha S, Liu Q, Mulrooney DA, Smith SA, Leisenring WM, Gibson TM, Jessen Chow E, Oeffinger KC, Robison LL, Armstrong GT, Constine LS, Hoppe B, Lee C, Yasui Y, Howell RM. Low-dose radiation to cardiac substructures and late-onset cardiac disease: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 39(15), 2021. e-Pub 2021.
Wong FL, Lee JM, Leisenring WM, Neglia JP, Howell RM, Smith SA, Oeffinger KC, Moskowitz CS, Henderson TO, Mertens A, Nathan PC, Yasui Y, Landier W, Armstrong GT, Robison LL, Bhatia S. Efficacy and cost-effectiveness of breast cancer (BC) screening in female survivors of childhood Hodgkin lymphoma (HL). J Clin Oncol 39(15), 2021. e-Pub 2021.
Brooks F, Glenn M, Pollard-Larkin J, Howell RM, Peterson C, Nelson C, Clark C, Kry S. The Impact of Treatment Planning System Errors on Patient Dose Delivery. Med Phys 48(6), 2021. e-Pub 2021.
Edward S, Kry S, Peterson C, Howell RM, Balter P, Pollard-Larkin J. Treatment Delivery Errors as a Component of IROC Phantom Dose Deviations. Med Phys 48(6), 2021. e-Pub 2021.
Gronberg M, Gay S, Beadle B, Olanrewaju A, Cardenas C, Howell RM, Peterson C, Fuller C, Jhingran A, Netherton T, Rhee D, Court L. Physician Evaluation of Deep Learning-Based Dose Predictions for Head and Neck Radiotherapy. Med Phys 48(6), 2021. e-Pub 2021.
Gupta A, Owens C, Netherton T, Lee C, Shrestha S, Smith S, Weathers R, Kry S, Balter P, Followill D, Long J, Howell RM. Implementation and Validation of Non-Uniform Body Region Specific 3D Age Scaling Factors (ASF) to Scale Whole-Body Computed Tomography (CT) Anatomy to Any Arbitrary Age. Med Phys 48(6), 2021. e-Pub 2021.
Hartzell S, Guan F, Taylor P, Peterson C, Howell RM, Kry S. Contribution of Nuclear Fragmentation to Dose and Relative Biological Effectiveness (RBE) Across Common RBE Models in Carbon Radiotherapy. Med Phys 48(6), 2021. e-Pub 2021.
Kry S, Lye J, Clark C, Andratschke N, Dimitriadis A, Followill D, Howell RM, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. A Consensus Report from the Global Harmonisation Group On Clinical Trials: Report Dose-To-Medium. Med Phys 48(6), 2021. e-Pub 2021.
Netherton T, Nguyen C, Cardenas C, Chung C, Klopp A, Colbert L, Rhee D, Peterson C, Howell RM, Balter P, Court L. A Fully Automated Approach for Labeling, Contouring, and Treatment Planning of Vertebral Bodies, Including Automatic Verification to Prevent Errors. Med Phys 48(6), 2021. e-Pub 2021.
Owens C, Rigaud B, Ludmir E, Gupta A, Shrestha S, Paulino A, Peterson C, Kry S, Smith S, Brock K, Howell RM. From Person-Specific to Population-Based Colorectal Models: An Age-Scalable Computational Anatomical Colorectal Model for Radiation Dosimetry in Late Effects Studies of Childhood Cancer Survivors. Med Phys 48(6), 2021. e-Pub 2021.
Noyd DH, Yasui Y, Li N, Jessen Chow E, Bhatia S, Landstrom A, Gilchrist S, Tonorezos ES, Zullig LL, Casillas JN, Madelon Berkman A, Ness KK, Mulrooney DA, Leisenring WM, Howell CR, Shoag JM, Kirchhoff AC, Howell RM, Armstrong GT, Oeffinger KC. Disparities in cardiovascular risk factors by race/ethnicity among adult survivors of childhood cancer: A report from the Childhood Cancer Survivorship Study (CCSS). J Clin Oncol 39(15), 2021. e-Pub 2021.
Shrestha S, Bates J, Liu Q, Smith S, Mulrooney D, Gupta A, Owens C, Leisenring W, Gibson T, Chow E, Oeffinger K, Robison L, Armstrong G, Constine L, Hoppe B, Lee C, Court L, Kry S, Yasui Y, Howell RM. Relationship Between Coronary Artery Radiation Doses and Risk of Late Coronary Artery Disease: A Report from the Childhood Cancer Survivor Study (CCSS). Med Phys 48(6), 2021. e-Pub 2021.
Phillips NS, Stratton K, Williams AM, Liu W, Ahles T, Ness KK, Gibson TM, Banerjee P, Yasui Y, Oeffinger KC, Jessen Chow E, Howell RM, Robison LL, Armstrong GT, Leisenring WM, Krull KR. Accelerated cognitive decline in adult survivors of pediatric central nervous system (CNS) tumors: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 39(15), 2021. e-Pub 2021.
Ghosh T, Chen Y, Dietz AC, Armstrong GT, Howell RM, Mulrooney DA, Turcotte LM, Yuan Y, Yasui Y, Neglia JP. Lung cancer as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 38(15), 2020. e-Pub 2020.
Shrestha S, Liu Q, Bates J, Yasui Y, Gupta A, Owens C, Smith S, Weathers R, Lee C, Hoppe B, Leisenring W, Oeffinger K, Constine L, Mulrooney D, Armstrong G, Howell RM. Impact of Enhanced CT-Based Heart Model on Estimating Radiation Therapy Related Late-Onset Cardiac Disease in the Childhood Cancer Survivor Study. Med Phys 47(6):E464-E464, 2020. e-Pub 2020.
Owens C, Gupta A, Shrestha S, Smith S, Lee C, Peterson C, Paulino A, Kry S, Followill D, Howell RM. Development of An Age-Scalable Colon Model with Substructures for Colon Radiation Therapy Dosimetry in Large Pediatric Cohorts for Late-Effects Studies. Med Phys 47(6):E743-E744, 2020. e-Pub 2020.
Netherton TJ, Rhee DJ, Cardenas CE, Chung C, Klopp AH, Peterson CB, Howell RM, Balter PA, Court LE. Evaluation of a multiview architecture for automatic vertebral labeling of palliative radiotherapy simulation CT images. Med Phys 47(11):5592-5608, 2020. e-Pub 2020.
Netherton T, Rhee D, Cardenas C, Chung C, Klopp A, Colbert L, Nguyen C, Kolluru V, Douglas R, Peterson C, Howell RM, Balter P, Court L. Automation of Palliative Radiotherapy Treatment Planning Using Independent Models to Prevent Errors From Propagating Through the Planning Process. Med Phys 47(6):E331-E331, 2020. e-Pub 2020.
Gupta A, Owens C, Shrestha S, Smith S, Weathers R, Howell RM. Development of Patient Height-Specific 3D Age-Scaling Factors to Generate DICOM Computational Phantoms for Retrospective Late-Effects Studies. Med Phys 47(6):E746-E746, 2020. e-Pub 2020.
Gupta A, Owens C, Shrestha S, Lee C, Balter P, Smith S, Weathers R, Kry S, Followill D, Long J, Howell RM. Investigation On the Use of Our 3D Age-Scaling Functions (ASF) to Scale Whole-Body Regions to Any Arbitrary Age. Med Phys 47(6):E806-E807, 2020. e-Pub 2020.
Gronberg M, Tailor R, Smith S, Kry S, Followill D, Stojadinovic S, Niedzielski J, Lindsay P, Krishnan S, Aguirre J, Fujimoto T, Taniguchi C, Howell RM. A Multi-Institutional End-To-End Dosimetry Mail Audit for Orthovoltage Small Animal Irradiators. Med Phys 47(6):E448-E448, 2020. e-Pub 2020.
Glenn MC, Peterson CB, Howell RM, Followill DS, Pollard-Larkin JM, Kry SF. Sensitivity of IROC phantom performance to radiotherapy treatment planning system beam modeling parameters based on community-driven data. Med Phys 47(10):5250-5259, 2020. e-Pub 2020.
Glenn M, Peterson C, Howell RM, Followill D, Pollard-Larkin J, Kry S. The Role of Beam Modeling Errors in IROC Houston Phantom Failures. Med Phys 47(6):E273-E273, 2020. e-Pub 2020.
Edward SS, Glenn MC, Peterson CB, Batter PA, Pollard-Larkin JM, Howell RM, Followill DS, Kry SF. Dose calculation errors as a component of failing IROC lung and spine phantom irradiations. Med Phys 47(9):4502-4508, 2020. e-Pub 2020.
Baltz G, Briere T, Luo D, Howell RM, Krafft S, Han E. 3D-Printed Headrest for Frameless Gamma Knife Radiosurgery: Design and Validation. Med Phys 47(6):E675-E675, 2020. e-Pub 2020.
Alvarez P, Howell RM, Followill D, Smith S. Evaluation of the Response of TLD Capsules and OSLD Nanodot Dosimeters in the Presence of a Magnetic Field. Med Phys 47(6):E775-E775, 2020. e-Pub 2020.
Weil B R, Green DM, Murphy AJ, Liu Q, Howell RM, Weldon CB, Mullen EA, Madenci AL, Leisenring WM, Neglia JP, Oeffinger KC, Termuhlen AM, Mostoufi-Moab S, Levine J, Krull KR, Yasui Y, Robison LL, Armstrong GT, Chow EJ, Armenian S. Treatment intensity and risk of chronic health conditions and late mortality among long-term survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study. J Clin Oncol 38(15), 2020. e-Pub 2020.
Trendowski M R, Baedke J, Sapkota Y, El Charif O, Wheeler HE, Leisenring WM, Robison LL, Hudson MM, Morton LM, Oeffinger KC, Travis LB, Howell RM, Yasui Y, Armstrong GT, Bhatia S, Dolan ME. Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the childhood cancer survivor study and the St. Jude Lifetime Cohort. J Clin Oncol 38(15), 2020. e-Pub 2020.
Rodwin RL, Chen Y, Yasui Y, Leisenring WM, Gibson TM, Nathan PC, Howell RM, Krull KR, Mohrmann C, Hayashi RJ, Chow EJ, Oeffinger KC, Armstrong GT, Ness KK, Lottick NSK. Neuromuscular dysfunction and associated health/socioeconomic outcomes: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Oncol 38(15), 2020. e-Pub 2020.
Im C, Li N, Moon W, Morton LM, Leisenring WM, Howell RM, Oeffinger KC, Sklar CA, Wilson CL, Sapkota Y, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y. HAGHL genetic variants increase first fracture risk (FFR) in female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE). J Clin Oncol 38(15), 2020. e-Pub 2020.
Dixon S, Lu L, Wilson CL, Jefferies JL, Merchant TE, Howell RM, Ness KK, Srivastava DK, Hudson MM, Robison LL, Chemaitilly W, Armstrong GT. Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort. J Clin Oncol 38(15), 2020. e-Pub 2020.
Gupta A, Qiao Y, Lee C, Ditty C, Smith S, Weathers R, Shrestha S, Hernandez S, Howell R. Implementation of 3D computational humanphantoms in raystation for retrospective studies in late effects. Med Phys 46(6):E586-E586, 2019. e-Pub 2019.
Hernandez S, Weathers R, Gupta A, Shrestha S, Smith S, Lee C, Bradley J, Hall M, Jackson A, Constine L, Howell R. Dose estimation for a PENTEC late effects study. Med Phys 46(6):E585-E585, 2019. e-Pub 2019.
Roed Y, Cardan R, Shaitelman S, Craft D, Howell R, Jhingran A, Popple R, Court L. 3D, CT-free breast treatment planning simulation for low- and middle- income countries: proof of concept. Med Phys 46(6):E104-E104, 2019. e-Pub 2019.
Shrestha S, Gupta A, Lee C, Smith S, Qiao Y, Weathers R, Howell R. Development of an enhanced heart model with substructures for cardiac dosimetry in late effect studies. Med Phys 46(6):E313-E313, 2019. e-Pub 2019.
Howell R, Bates J, Qi L, Hoppe B, Lee C, Smith SA, Oeffinger KC, Constine LS, Leisenring WM, Mulrooney DA, Gibson TM, Armstrong GT, Yasui Y. Effect of heart anatomy on radiation related cardiac risk in the Childhood Cancer Survivor Study 133:S485-S486, 2019. e-Pub 2019.
Glenn M, Followill D, Howell R, Pollard-Larkin J, Zhou S, Kry S. A pilot study on the sensitivity of common beam modeling parameters in Eclipse 133:S44-S44, 2019. e-Pub 2019.
Edward S, Glenn M, Balter P, Pollard-Larkin J, Peterson C, Howell R, Kry S. Examining the magnitude of dose calculation errors as a component of IROC lung and spine phantom failures. Med Phys 46(6):E530-E530, 2019. e-Pub 2019.
Ger R, Zhou S, Mackin D, Elhalawani H, Elgohari B, Meier J, Fuller C, Howell R, Layman R, Li H, Mawlawi O, Stafford R, Court L. Harmonizing imaging protocols: impact on radiomics survival prediction in large patient cohorts. Med Phys 46(6):E524-E524, 2019. e-Pub 2019.
Glenn M, Followill D, Howell R, Pollard-Larkin J, Peterson C, Kry S. Sensitivity analysis of common beam modeling parameters. Med Phys 46(6):E630-E631, 2019. e-Pub 2019.
Ger RB, Zhou SH, Chi PCM, Goff DL, Zhang LF, Lee HJ, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE, Mackin DS. Quantitative image feature variability amongst CT scanners with a controlled scan protocol. Med Imag: Computer-Aided Diagnosis 10575, 2018. e-Pub 2018.
NethertonT, Cardenas C, Klopp A, Baker P, Chung C, Peterson C, Howell R, Court L. Automated detection of vertebral body metastases for fully-automated palliative radiotherapy using transfer learning. Med Phys 45(6):E449-E449, 2018. e-Pub 2018.
Kry S, Peterson C, Howell R, Izewska J, Lye J, Clark C, Nakamura M, Hurksman C, Followill D, Alvarez P, Taylor P, Leif J, Molineu A, Weathers R, Palmer J, Bokulic T, Kazantsev P, Williams I, Alves A. Global findings of remote beam output audits; a review by the Global Harmonisation Group 127:S1218-S1219, 2018. e-Pub 2018.
Ntentas G, Aznar MC, Hodgson DC, Howell RM, Maraldo MV, Ahmed S, Ng A, Darby SC, Cutter DJ. Cardiac radiation dose reconstruction in the study of late effects: A comparison of different methods 127:S1091-S1092, 2018. e-Pub 2018.
Howell R, Smith S, Palmer J. 15 years of independent peer review results of beam output at more than 2000 Institutions Worldwide 127:S939, 2018. e-Pub 2018.
Ger R, Mackin D, Zhou S, Chi P, Lee H, Layman R, Jones A, Goff D, Fuller C, Howell R, Li H, Stafford R, Court L. Harmonized CT protocols for high quality radiomics studies. Med Phys 45(6):E677-E678, 2018. e-Pub 2018.
Glenn M, Followill D, Howell R, Pollard-Larkin J, Zhou S, Kry S. Treatment planning system beam modeling parameters exhibit high variation among radiotherapy institutions. Med Phys 45(6):E653-E653, 2018. e-Pub 2018.
Peters M, Howell R, Tailor R, Smith S, Kry S, Niedzielski J, Followill D, Craft D, Fujimoto T, Taniguchi C, Krishnan S. Development of an independent peer review system for a small animal irradiator. Med Phys 45(6):E559-E559, 2018. e-Pub 2018.
Wang ZM, Wilson CL, Easton J, Thrasher A, Mulder H, Liu Q, Hedges DJ, Wang SG, Rusch MC, Edmonson MN, Levy S, Lanctot JQ, Caron E, Shelton K, Currie K, Lear M, Patel A, Rosencrance C, Shao Y, Vadodaria B, Yergeau D, Sapkota Y, Brooke RJ, Moon W, Rampersaud E, Ma XT, Chang TC, Rice SV, Pepper C, Zhou X, Chen X, Chen WA, Jones A, Boone B, Ehrhardt MJ, Krasin MJ, Howell RM, Phillips NS, Lewis C, Srivastava D, Pui CH, Kesserwan CA, Wu G, Nichols KE, Downing JR, Hudson MM, Yasui Y, Robison LL, Zhang JH. Genetic risk for subsequent neoplasms among long-term survivors of childhood cancer. J Clin Onc 36(20):2078, 2018. e-Pub 2018.
Weil BR, Madenci AL, Liu Q, Howell RM, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Smith SA, Tonorezos ES, Friedman DN, Constine LS, Tinkle CL, Diller LR, Armstrong GT, Oeffinger KC, Weldon CB. Late infection-related mortality in asplenic survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Onc 36(16):1571, 2018. e-Pub 2018.
Craft D, Kry S, Balter P, Woodward W, Salehpour M, Baltz G, Peters M, Howell R. Design and validation of 3D printed patient specific tissue compensators for post mastectomy radiation therapy. Med Phys 45:E558-E559, 2018. e-Pub 2018.
Ger R, Mackin D, Zhou S, Chi P, Lee H, Layman R, Jones A, Goff D, Fuller C, Howell R, Li H, Stafford R, Court L. Harmonized CT Protocols for high quality radiomics studies. Med Phys 45:E677-E678, 2018. e-Pub 2018.
de Blank P, Li N, Ullrich N, Fisher MJ, Bhatia S, Yasui Y, Sklar C, Leisenring W, Howell R, Oeffinger K, Hardy K, Okcu MF, Gibson T, Robison L, Armstrong GT, Krull K. Effect of neurofibromatosis type 1 on long-term health outcomes in adult survivors of childhood astrocytoma: A report from the Childhood Cancer Survivor Study (CCSS). Neuro-Onc 20:142-142, 2018. e-Pub 2018.
Daniel LC, Wang M, Srivastava D, Schwartz L, Brinkman T, Edelstein K, Mulrooney D, Zhou E, Howell R, Gibson T, Leisenring W, Armstrong GT, Krull K. Sleep behaviors and patterns in adult survivors of childhood cancers: A report from the Childhood Cancer Survivor Study (CCSS). Sleep 41:A321-A321, 2018. e-Pub 2018.
Friedman DN, Hilden P, Moskowitz CS, Howell RM, Weathers R, Smith SA. Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Onc 36(15), 2018. e-Pub 2018.
Craft D, Kry S, Balter P, Woodward W, Salehpour M, Baltz G, Peters M, Howell R. Design and validation of 3D printed patient specific tissue compensators for post mastectomy radiation therapy. Med Phys 45(6):E558-E559, 2018. e-Pub 2018.
Baltz GC, Chi P, Wong P, Wang C, Craft D, Kry S, Lin S, Garden AS, Howell RM. Validation of patient-specific 3D-printed bolus caps for clinical use in total scalp irradiation. Med Phys 45(6):E595-E596, 2018. e-Pub 2018.
Oeffinger KC, Stratton K, Hudson MM, Leisenring W, Howell RM, Wolden SL. Risk-adapted therapy for pediatric hodgkin lymphoma (HL) results in lower risk of late effects: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Onc 36(15), 2018. e-Pub 2018.
Moskowitz CS, Chou JF, Neglia JP, Howell RM, Diller L, Partridge A. Mortality following breast cancer in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS). J Clin Onc 36(15), 2018. e-Pub 2018.
Craft D, Kry S, Balter P, Salehpour M, Woodward W, Howell R. 3D printed material uncertainty and its consequences for radiation oncology applications 127:S930-S931, 2018. e-Pub 2018.
Gibson TM, Mostoufi-Moab S, Stratton K, Barnea D, Chow EJ, Donaldson SS, Howell RM, Hudson MM, Leisenring WM, Mahajan A, Nathan PC, Ness KK, Sklar CA, Tonorezos ES, Weldon CB, Wells EM, Yasui Y, Armstrong GT, Robison LL, Oeffinger KC. Temporal trends in chronic disease among survivors of childhood cancer diagnosed across three decades: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr LBA10500, 2017. e-Pub 2017.
Kisling K, Zhang L, Jhingran A, Yang J, Simonds H, McCarroll R, du Toit M, Balter P, Howell R, Schmeler K, Bogler O, Beadle B, Court L. Dose escalated radiation therapy for advanced stage lung cancer. Med Phys 44(6):3308-3309, 2017. e-Pub 2017.
Howell R, Smith S, Palmer J. Results from 15 years of independent peer review of beam output at more than 2000 academic and non-academic institutions. Med Phys 44(6):3164-3164, 2017. e-Pub 2017.
Peters M, Craft D, Balt G, Followill D, Howell R. Dual-material 3D printing of an anthropomorphic head phantom. Med Phys 44(6), 2017. e-Pub 2017.
Ger R, Mohamed A, Awan M, Ding Y, Li K, Fave X, Beers A, Driscoll B, Elhalawani H, Hormuth D, van Houdt P, He R, Zhou S, Mathieu K, Li H, Coolens C, Chung C, Bankson J, Huang W, Wang J, Sandulache V, Lai S, Howell R, Stafford R, Yankeelov T, van der Heide U, Frank S, Barboriak D, Hazle J, Court L, Kalpathy-Cramer J, Fuller C. Comparison of parameter calculation algorithms for DCE-MRI: Results from a multi-institutional study. Med Phys 44(6):3097-3097, 2017. e-Pub 2017.
Craft DF, Peters M, Baltz G, Howell RM. Comparison of single and dual material 3D printed patient-specific radiotherapy phantoms. Med Phys 44(6):2877, 2017. e-Pub 2017.
Craft DF, Howell RM. Material matters: Concerns with 3D printed material consistency. Med Phys 44(6):2877, 2017. e-Pub 2017.
Baltz G, Chi P, Craft D, Peters M, Pollard J, Howell R. Use and validation of countered 3D-printed neck compensators for total body irradiation. Med Phys 44(6):2947-2947, 2017. e-Pub 2017.
Brooke RJ, Chemaitilly W, Wilson CL, Krasin MJ, Li Z, Im C, Morton LM, Wu G, Wang Z, Chen W, Howell RM, Armstrong GT, Bhatia S, Chanock SJ, Zhang J, Green DM, Sklar CA, Hudson MM, Robison LL, Yasui Y. A high-risk genetic profile for premature menopause (PM) in childhood cancer survivors (CCS) exposed to gonadotoxic therapy: A report from the St. Jude Lifetime Cohort (SJLIFE) and Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10502, 2017. e-Pub 2017.
Morton LM, Veiga L, Curtis RE, Withrow D, Inskip P, Oeffinger KC, Moskowitz CS, Neglia J, Turcotte LM, Howell RM, Weathers R, Smith SA, Henderson TO, Leisenring WM, Whitton J, Gibson TM, Robison LL, Armstrong GT, Berrington De Gonzalez A. Risk of subsequent breast cancer after radiotherapy according to hormone-receptor status: A nested case-control study in the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr10520, 2017. e-Pub 2017.
Madenci AL, Weil B, Liu Q, Gibson TM, Yasui Y, Leisenring WM, Howell RM, Tinkle C, Nekhlyudov L, Diller L, Armstrong GT, Oeffinger KC, Weldon CB. Long-term incidence of venous thromboembolism (VTE) among survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10562, 2017. e-Pub 2017.
Salloum R, Chen Y, Yasui Y, Packer R, Leisenring WM, Wells EM, King AA, Howell RM, Gibson TM, Krull KR, Robison LL, Oeffinger KC, Fouladi M, Armstrong GT. Temporal trends in late-onset morbidity and mortality after medulloblastoma diagnosed across three decades: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10516, 2017. e-Pub 2017.
Bates JE, Liu Q, Yasui Y, Howell RM, Mulrooney DA, Dhakal SD, Leisenring WM, Indelicato DJ, Gibson TM, Armstrong GT, Oeffinger KC, Constine LS. Age-associated vulnerability to treatment-related late cardiotoxicity: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10501, 2017. e-Pub 2017.
Weil B, Madenci AL, Liu Q, Gibson TM, Yasui Y, Neglia JP, Leisenring WM, Howell RM, Tonorezos ES, Friedman DN, Tinkle C, Diller L, Armstrong GT, Oeffinger KC, Weldon CB. Infection related late mortality in survivors of childhood cancer with asplenia or radiation-induced hyposplenism: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10563, 2017. e-Pub 2017.
Henderson TO, Nathan PC, Whitton J, Leisenring WM, Neglia JP, Fowler B, Arnold MA, Howell RM, Robison LL, Armstrong GT, Alexander K. Human papillomavirus (HPV)-associated malignancies as subsequent malignant neoplasms (SMN) in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10566, 2017. e-Pub 2017.
Dietz AC, Seidel K, Leisenring WM, Mulrooney DA, Tersak JM, Glick RD, Burnweit CA, Green DM, Diller L, Oeffinger KC, Smith SA, Howell RM, Stovall MA, Robison LL, Armstrong GT. Solid organ transplant after treatment for childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10559, 2017. e-Pub 2017.
Foster RH, Hayashi RJ, Wang M, Liu W, Mohrmann C, Howell RM, Sa S, Gibson TM, Kumar Srivastava D, Green DM, Oeffinger KC, Leisenring WM, Robison LR, Armstrong GT, Krull KR, Hardy KK. Psychological and educational outcomes among adolescent survivors of wilms tumor: A report from the Childhood Cancer Survivor Study (CCSS) 35(suppl):abstr 10049, 2017. e-Pub 2017.
Ger R, Yang J, Ding Y, Jacobsen M, Fuller C, Howell R, Li H, Stafford R, Zhou S, Court L. Assessment of the accuracy of DIR on MR images using velocity and an in-house demons algorithm. Med Phys 44(6):3097-3097, 2017. e-Pub 2017.
Craft D, Woodward W, Kanke J, Kry S, Salehpour M, Howell R. Use and validation of flexible 3D printed tissue compensators for post-mastectomy radiation therapy. Med Phys 43:3767, 2016. e-Pub 2016.
Kerns J, Followill D, Howell RM, Melancon M, Stingo F, Kry S. Identifying treatment planning system errors in IROC-H phantom irradiations. Med Phys 43:3713, 2016. e-Pub 2016.
Ger R, Awan M, Mohamed A, Ding Y, Frank S, Howell R, Li H, Liu H, Mohan R, Schellingerhout D, Stafford R, Wang J, Fuller C, Court L. Investigation of longitudinal salivary gland DCE-MRI changes. Med Phys 43:3829, 2016. e-Pub 2016.
Howell RM. Making the most of a one hour lecture with alternative teaching methodologies: Implementing project-based and flipped learning. Med Phys 43:3312, 2016. e-Pub 2016.
Howell RM. Practical implementation of deep inspiration breath hold techniques for breast radiation therapy. Med Phys 43:3816, 2016. e-Pub 2016.
Howell, RM. Task group 158: Measurement and calculation of doses outside the treatment volume from external-beam radiation therapy treatment. Med Phys 43:3747, 2016. e-Pub 2016.
Craft DF, Woodward WA, Kanke J, Kry SF, Howell RM. Use of flexible 3-dimensional printed materials for in-house fabrication of patient-specific tissue equivalent compensators for postmastectomy radiation therapy. Int J Radiat Oncl Biol Phys 96(2):E644, 2016. e-Pub 2016.
Kisling K, Zhang L, Yang J, Jhingran A, Balter P, McCarroll R, Beadle B, Howell R, Schmeler K, Court L. Automating treatment planning for cervical cancer in low- and middle- income countries. Med Phys 43:3560, 2016. e-Pub 2016.
Cardenas C, Nitsch P, Kudchadker R, Howell R, Kry S. Characterization of electron beam out-of-field doses and neutron contamination from modern Varian and Elekta linear accelerators. Med Phys 43:3849, 2016. e-Pub 2016.
Taylor P, Craft D, Followill D, Howell R. Proton therapy tissue-equivalence of 3D printed materials. Med Phys 43:3503, 2016. e-Pub 2016.
Kerns J, Howell RM, Followill D, Melancon A, Stingo F, Kry S. Validation of a secondary TPS for IROC-H recalculation of anthropomorphic phantoms. Med Phys 42:3519, 2015. e-Pub 2015.
Howell RM. Task Group 158: Measurement and calculation of doses outside the treatment volume from external-beam radiation therapy treatment. Med Phys 42:3747, 2015. e-Pub 2015.
Cardenas C, Nitsch P, Kudchadker R, Howell RM, Kry S. An evaluation of out-of-field doses for electron beams from modern Varian and Elekta linear accelerators. Med Phys 42:3637, 2015. e-Pub 2015.
Huang J, Followill D, Howell RM, Liu X, Mirkovic D, Stingo F, Kry S. Dosometric impact of implementing metal artifact reduction methods and metal energy deposition kernels for photon dose calculations. Medl Phys 42:3409, 2015. e-Pub 2015.
Ger R, Burgett EA, Price RR, Craft DF, Kry SF, Howell RM. Pseudo in vivo patient dosimetry using a 3D-printed patient-specific phantom. Med Phys 42:3667, 2015. e-Pub 2015.
Howell RM. Dosimeters and phantoms for measuring non-target photon, electron, and neutron doses. Med Phys 42:3747, 2015. e-Pub 2015.
Petersen I, Mayo CM, Shaitleman SF, Yan ES, Martel ME, Park SS, Woodward WA, Mutter RW, Howell RM. What is normal?: Cooperative pooled database to establish typical heart and lung doses for modern breast radiation therapy 90(1):S263-S264, 2014. e-Pub 2014.
Huang J, Kerns J, Nute J, Liu X, Stingo F, Followill D, Mirkovic D, Howell R, Kry S. Evaluation of three commercial metal artifact reduction methods for CT simulations in radiation therapy treatment planning. Med Phys 41:498, 2014. e-Pub 2014.
Pulliam K, Kerns J, Howell R, Followill D, O'Daniel J, Kry S. A survey of IMRT QA practices for more than 800 institutions. Med Phys 41:432, 2014. e-Pub 2014.
Mayo C, Miller R, Sloan J, Wu Q, Howell R. Radiation oncology outcomes informatics. Med Phys 41:530, 2014. e-Pub 2014.
Starkschall G, Kry S, Howell R. "Stop lecturing me!” - New methods for teaching medical physics. Med Phys 41:420, 2014. e-Pub 2014.
Howell RM, Tereffe W, Stauder MC, Stingo F, Strom EA, Perkins GH, Smith BD, Woodward WA, Hoffman KE, Buchholz TA, Salehpour M, Kry S, Barcenas CH, Yusuf WS, Shaitleman S. Toward developing survivorship care plans for breast cancer patients at high risk for radiation-related cardiac effects 90(1):S857-S858, 2014. e-Pub 2014.
Huang J, Eklund D, Childress N, Howell R, Mirkovic D, Kry S. Dosimetric impact of implementing kernel hardening and material‐specific kernels in the convolution/superposition method. Med Phys 40:333, 2013. e-Pub 2013.
Wang X, Salehpour M, Howell R, Melancon A, Sun T, Woodward W, Smith B. Evaluation of setup uncertainties for electron boost field treated using compression device for breast cancer irradiation. Med Phys 40:151, 2013. e-Pub 2013.
Eley J, Friedrich T, Homann K, Mahajan A, Durante M, Bert C, Howell R, Scholz M, Newhauser W. Risk of developing a second cancer in the breast for hodgkin lymphoma patients receiving carbon ion therapy versus proton therapy. Med Phys 40:268, 2013. e-Pub 2013.
Howell R, Newhauser W, Burgett E. Measurements of secondary neutron spectrum and dose equivalent from a 250 MeV passively scattered proton beam using an extended range bonner sphere spectrometer. Med Phys 40:493, 2013. e-Pub 2013.
Howell R, Kry S, Titt, U. Project based learning - Expanding course content with a broad‐scope project. Med Phys 40:413, 2013. e-Pub 2013.
Homann K, Newhauser WD, Howell R, Eley J. Voxelized second cancer risk calculation — Comparison of proton and photon radiotherapies for hodgkin lymphoma. Med Phys 40:267, 2013. e-Pub 2013.
Zhang R, Howell R, Homann K, Giebeler A, Taddei P, Mahajan A, Newhauser WD. Risks of cardiac toxicity in pediatric atients receiving photon or proton radiotherapy. Med Phys 40:269, 2013. e-Pub 2013.
Han T, Tailor R, Melancon A, Howell R, Mourtada F, Salehpour M. A comprehensive investigation of dosimetric uncertainties in junction region of breast superclavicular and tangential fields. Med Phys 40:86, 2013. e-Pub 2013.
Han T, Tailor R, Laneave S, Howell R, Mourtada F, Salehpour M. SU-E-T-528: Appraisal of Acorus XB and convolution dose algorithms in field junction of breast tangential/superclavicular fields. Med Phys 39(6):3827, 2012. e-Pub 2012. PMID: 22756707.
Kry S, Howell R. WE-A-213AB-01: Second cancers from radiation therapy procedures. Med Phys 39(6):3930-1, 2012. e-Pub 2012. PMID: 22757127.
Eley J, Graeff C, Lu¨chtenborg R, Durante M, Howell R, Newhauser W, Bert C. WE-G-213CD-01: 4D optimization for scanned ion beam tracking therapy for moving tumors. Med Phys 39(6):3970, 2012. e-Pub 2012. PMID: 22757287.
Casey K, Alvarez P, Lawyer A, Kry S, Howell R, Davidson S, Followill D. SU-E-T-81: Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry. Med Phys 39(6):3721, 2012. e-Pub 2012. PMID: 22756261.
Homann K, Howell R, Giebeler A, Eley J, Randeniya K, Newhauser W. SU-C-BRB-01: Radiogenic second cancer risk differences in female hodgkin lymphoma patients treated with proton versus photon radiotherapies. Med Phys 39(6):3601, 2012. e-Pub 2012. PMID: 22755762.
Repchak R, Molineu A, Popple R, Kry S, Howell R, Followill D. SU-E-T-447: Evaluation of the anisotropic analytical algorithm (AAA) heterogeneity correction dose calculation in flattened and flattening-filter-free (FFF) beams for high energy x-ray beams using the radiological physics center (RPC) lung phantom. Med Phys 39(6):3807, 2012. e-Pub 2012. PMID: 22756626.
Han T, Mourtada F, Repchak R, Tonigan J, Mikell J, Howell R, Salehpour M, Molineu A, Followill D. SU-E-T-519: Experimental evaluation of deterministic acuros XB radiation transport algorithm for heterogeneity dose calculation using the radiological physics center's lung phantom. Med Phys 39(6):3825, 2012. e-Pub 2012. PMID: 22756698.
Rechner L, Howell RM, Zhang R, Lee A, Newhauser W. Risk of second malignant neoplasms following VMAT and proton arc therapy for prostate cancer. Med Phys 38:3826, 2011. e-Pub 2011.
Zhang R, Howell RM, Giebeler A, Taddei P, Mahajan A, Newhauser W. Calculation of the risks of second cancer and cardiac toxicities for a pediatric patient treated with photon and proton radiotherapies. Med Phys 38:3495, 2011. e-Pub 2011.
Taddei P, Jalbout W, Khater N, Geara RB, Mirkovic D, Howell RM, Zhang R, Giebeler A, Mahajan A, Newhauser W. Comparison of the risk of second malignant neoplasm in a developed country versus a developing country for a 13-year-old girl receiving craniospinal irradiation. Med Phys 38:3736, 2011. e-Pub 2011.
Randeniya S, Mirkovic D, Kry S, Titt U, Newhauser W, Howell RM. Patient specific out-of-field dose calculation tool for 6MV and 18MV: Development and validation. Med Phys 38:3736, 2011. e-Pub 2011.
Pulliam K, Howell RM, Followill D, Luo D, White R, Kry S. Clinical impact of couch top and couch rails on treatment dose for IMRT and arc therapy. Med Phys 38:3592, 2011. e-Pub 2011.
Mayo C, Garces Y, Dong L, Howell RM. Planning, QA, and the role of imaging of localization for head and neck treatments. Med Phys 38:3738, 2011. e-Pub 2011.
Howell RM, Newhauser W. Late effects from radiation therapy, cardiac toxicity and second cancers, educational course therapy. Med Phys 38:3849, 2011. e-Pub 2011.
Han T, Mourtada F, Kisling K, Mikell J, Followill D, Howell RM. Dosimetric veification of deterministic acuros XB radiation transport algorithm for IMRT and VMAT plans with the RPC H&N phantom. Med Phys 38:3656, 2011. e-Pub 2011.
Giebeler A, Howell RM, Zhang R, Etzel C, Mahajan A, Newhauser W. A method to increase statistical power in micro-clinical trials for second cancers following advanced techniques for pediatric radiotherapy. Med Phys 38:3496, 2011. e-Pub 2011.
Scarboro S, Kry S, Howell R, Followill D. Variations in 6 MV photon energy spectra impact the response of TLD. Med Phys 37:3330, 2010. e-Pub 2010.
Kisling K, Yaldo D, Followill D, Kry S, Scarboro S, Frank S, Howell R. Evaluation of rapidarc dose delivery using radiological physics center phantoms. Med Phys 37:3238, 2010. e-Pub 2010.
Kry S, Johnson J, White R, Howell R, Kudchadker R, Gillin M. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 37:3330, 2010. e-Pub 2010.
Yaldo D, Tailor R, Scarboro S, Sahoo N, Kry S, Kisling K, Followill D, Howell R. Evaluation of the sensitivity of the anisotropic analytical algorithm (AAA) to the commissioning dataset. Med Phys 37:3255, 2010. e-Pub 2010.
Randeniya S, Mirkovic D, Kry S, Titt U, Newhauser W, Howell R. Automated photon monte carlo linear accelerator model for calculating in-field and out-of-field dose. Med Phys 37:3281, 2010. e-Pub 2010.
Scarboro S, Stovall M, Smith S, Yaldo D, Kry S, White A, Howell R. Impact of stomach size and position on out-of-field organ dose. Med. Phys 36:2581, 2009. e-Pub 2009.
Howell R, Scarboro S, Kry S, Smith S, Yaldo D, Stovall M. How accurate are treatment planning system isodose values outside the treatment field?. Med. Phys 36:2591, 2009. e-Pub 2009.
Kry S, Howell R, Stovall M. Head leakage, collimator scatter, and patient scatter contributions to out-of-field dose. Med. Phys 36:2631, 2009. e-Pub 2009.
Kry S, Childress N, Howell R, Stovall M. Analytic technique to calculate the out-of-field dose from IMRT therapy. Med. Phys 36:2629, 2009. e-Pub 2009.
Burgett EA, Hertel NE, Howell RM. Measurements of high energy neutron spectra with a bonner sphere extension. Transactions of the American Nuclear Society:99, 2008. e-Pub 2008.
Wang Z, Kry SF, Burgett EB, Howell RM, Tailor R, Oliver J, Followill D, Smith AR, Salehpour M. Measurement of neutron spectrum and ambient dose equivalent around a mini-phantom at a proton therapy facility. Med Phys 35:2982, 2008. e-Pub 2008.
Howell RM, Kry SF, Garden A, Mohan R. Investigation of volumetric arc therapy for head and neck cancer 66(3):S24, 2008. e-Pub 2008.
Howell RM, Smith IPN, Jarrio CS. Clinical implementation of portal dosimetry-establishing action levels. Med Phys 34:2601, 2007. e-Pub 2007.
Howell RM, Burgett E, Shannon M, Hertel NE. Preliminary investigation-design of a bonner sphere extension for high energy neutron spectroscopy. Transactions-American Nuclear Society 96:333-334, 2007. e-Pub 2007.
Howell RM, Koontz-Raisig W, PASJ J. Prescription framework for lung dose calculations using anisotropic analytical algorithm for inhomogeneity corrections for lung cancer:34, 2007. e-Pub 2007.
Howell RM, Kry SF, Followill D, Hertel NE, Wang Z, Salehpour M. Investigation of MLC effects on secondary neutron spectra for Varian, Siemens, and Elekta. Med Phys 33:2249, 2006. e-Pub 2006.
Howell RM, Koontz-Raisig W, Johnstone PAS. The trade-off between neutron dose and skin dose for 6MV versus 18MV for prostate IMRT: does the 20cm rule still apply? 66(3 Supplement):S678, 2006. e-Pub 2006.
Howell RM, Hertel NE, Wang Z, Fullerton GD. Measurement of secondary neutron spectra from high energy IMRT and conventional treatment plans using bonner spheres with au-activation foils. Med Phys 32:2060, 2005. e-Pub 2005.
Koshy M, Paulino AC, Howell RM, Schuster D, Halkar R, Davis L. Volumetric analysis of the PET-CT defined target in intensity modulated radiotherapy for head and neck cancer 60(1):S492, 2004. e-Pub 2004.
Howell RM, Ferenci MS, Hertel NE, Fullerton GD. Preliminary investigation of secondary neutron dose for high energy IMRT. Med Phys 31(6):1831, 2004. e-Pub 2004.
Koshy M, Landry JC, Lawson JD, Esiashvili N, Staley CA, Howell RM, Ting JY, Davis LW. Potential for toxicity reduction using intensity modulated radiation therapy (IMRT) for retroperitoneal sarcoma 57(2):S448-S449, 2003. e-Pub 2003.

Book Chapters

Howell RM, Kry SF. Modulated arc therapy planning. In: Comprehensive Biomedical Physics. Elsevier, 395-400, 2014.

Less

CV information above last modified April 01, 2026

Rebecca M. Howell, PhD

About Rebecca M. Howell

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Other Articles

Editorials

Abstracts

Book Chapters

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Rebecca M. Howell, PhD

About Rebecca M. Howell

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Professional Educational Materials

Other Articles

Editorials

Abstracts

Book Chapters

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson